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ANTI-APOPTOTIC EFFECTS OF SPEEDYRINGO IN 
NEURODEGENERATION 
SUMMARY 
Neurons are known to be terminally differentiated non-mitotic cells. However, recent 
studies have shown an up-regulation of cell cycle markers causing abnormal re-
activation of cell cycle in neurons in case of neurodegeneration. This unprogrammed 
cell cycle re-entry is indicated to be one of the earliest pathological symptoms of the 
most of the neurodegenerative diseases, especially that of Alzheimer’s disease. In 
case of Alzheimer’s disease, neurons have been shown to leave the resting G0 phase 
and re-enter into cell cycle and even replicate their genomes, but this process cannot 
be successfully completed and degenerating neurons undergo apoptosis, since they 
do not have the mitotic machinery. 
There are a number of pathological conditions causing neurodegeneration such as 
amyloid beta aggregation, oxidative stress and metabolic alterations. Amyloid beta 
aggregation, a hallmark of Alzheimer’s disease, causes destabilization of calcium 
homeostasis, which ends up with the elevation of intracellular calcium levels leading 
to pathological activation of a calcium-sensitive cysteine-protease, calpain. Calpain 
over-activity has been shown to be very important in terms of causing cell cycle re-
activation and degeneration in neurons.  
Pathologic activation of calpain force neurons into apoptosis directly or indirectly. 
Indirect way is that overactivated calpain cleaves p35 protein into p25 and p10 
fractions. Under normal conditions, p35 is the partner for CDK5, which is a non-
mitotic neuron-specific kinase. They form CDK5/p35 complex that takes place in a 
number of cellular events in neurons. However, over-activity of calpain in neurons 
results in cleavage of p35 into p25 and p10 fractions, as p35 is a substrate of calpain. 
p25 is able to bind to CDK5 to form CDK5/p25 complex. However, this complex 
differs from CDK5/p35 complex in terms of localization and functions. Normally, 
Cyclin D-CDK4 complex is necessary for the activation of cell cycle. This complex 
drives cells through G1/S transition by pRb phosphorylation, but in case of calpain 
induction in neurons it has been shown that CDK5/p25 complex phosphorylates the 
pRb protein instead of Cyclin D-CDK4 complex and re-activates cell cycle driving 
neurons through G1/S transition. However, this abnormal cell cycle re-activation 
cannot be completed and neurons undergo apoptosis by an increase in p53 level. In 
addition, CDK5/p25 complex can activate p53 directly, as p53 is one of the 
substrates of CDK5. All these findings strongly indicate that calcium-mediated over-
activation of calpain causes an increase in p53 expression and activation, and 
ultimately ends up with caspase-dependent apoptosis in degenerating neurons. 
Direct way of calpain-mediated apoptosis is that p53 is the substrate of calpain itself 
and thus, calpain over-activation allows increased p53 expression and activation. 
Induced p53 triggers mitochondrial death signals and caspase-3 activation finally 
resulting in caspase-mediated apoptosis.  
xxiv 
 
Although cyclins are major players that take role in activation of CDKs to regulate 
progression of the cell cycle, there is a novel regulatory protein, SpeedyRINGO, 
which can activate CDKs. In addition to its role in regulating the cell cycle, 
SpeedyRINGO has also been indicated to take role in preventing caspase-dependent 
apoptosis in mitotic cells. 
Although main function of SpeedyRINGO is the regulation of cell cycle in mitotic 
cells, recent studies have also attributed a different role for SpeedyRINGO, such that 
it has an anti-apoptotic effect in DNA-damaged mitotic cells allowing cell survival. It 
has been shown that SpeedyRINGO prevents apoptosis in a p53-dependent manner 
in response to DNA damage in U2OS cells, which is a mitotic human osteosarcoma 
cell line. SpeedyRINGO was indicated to have strong protective effect in mitotic 
cells that encountered a number of extrinsic or intrinsic apoptotic factors such as UV 
irradiation. SpeedyRINGO fulfills this function by inhibiting caspase-3 activation 
and apoptosis in the presence of the gene regulatory protein p53.  
Therefore, major aim of this study was to regulate cell cycle reactivation and 
eliminate the apoptotic effects of pathologic calpain induction by expressing 
SpeedyRINGO in neurons.  
For this purpose, hippocampal neurons are electrophoretically transfected with 
SpeedyRINGO and then, calpain was induced by calcium ionophore. After that, 
QRT-PCR, immunofluorescence and western blotting analysis were performed to 
determine the changes in different cell cycle markers and in CDK5, Cyclin D1, p27, 
CDK2, p53 and active caspase-3 mRNA and protein levels in order to understand 
whether SpeedyRINGO could protect neurons against caspase-mediated apoptosis in 
the presence of p53. Results showed that calpain induction caused cell cycle re-
activation through CDK5 instead of Cyclin D, since mRNA and protein level of 
CDK5 increased, while Cyclin D levels did not change. Besides that, calpain 
induction resulted in p53 up-regulation and subsequent caspase-3 activation, whereas 
SpeedyRINGO expression prevented activation of caspase-3 in the presence of p53. 
Furthermore, DAPI staining and TUNEL assays were performed for detection of 
apoptosis. Apoptotic analysis supported these findings that calpain overactivated 
neurons were in early apoptotic stage, while SpeedyRINGO expressing calpain 
overactivated neurons were not apoptotic. 
In this study, it has been shown for the first time that caspase-3 activation after up-
regulation of p53 caused by calpain over-activity is prevented by Speedy/RINGO in 
degenerating neurons. Therefore, Speedy/RINGO acts as a lifesaver for degenerating 
neurons by inhibiting caspase-dependent apoptosis.  
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SPEEDYRİNGO PROTEİNİNİN NÖRODEJENRASYONDAKİ               
ANTİ-APOPTOTİK ETKİLERİ 
ÖZET 
Nöronlar terminal olarak farklılaşmalarını tamamlamış, bu nedenle de bölünme 
özelliklerini kaybetmiş hücrelerdir. Fakat,yapılan son çalışmalar göstermiştir ki 
nörodejenerasyon durumunda, hücre siklus belirteçlerinde belirgin bir artış olmakta 
ve bu artış nöronlarda hücre siklusunun normal olmayan bir şekilde aktifleşmesine 
aktive olmasına sebep olmaktadır. Bu programsız hücre siklus aktivasyonunun 
birçok nörodejeneratif hastalığın, özellikle de Alzheimer hastalığının en erken 
belirtilerinden biri olduğu kabul edilmektedir. Alzheimer hastalığında, nöronlar G0 
adı verilen dinlenme fazından çıkarak yeniden hücre siklusuna girmekte ve hatta 
genomlarını replike etmektedirler. Fakat bu proses, nöronlar mitotik mekanizmaya 
sahip olmadıklarından, başarılı bir şekilde tamamlanamamakta ve dejenerasyona 
uğrayan nöronlar apoptoza gitmektedirler. 
Amiloid beta birikimi, oksidatif stres, metabolik değişiklikler gibi bir çok sebep 
nöronları dejenerasyona sürüklemektedir. Özellikle, Alzheimer hastalığının en 
önemli işaretlerinden biri olan amiloid beta birikimi, nöronlardaki kalsiyum 
dengesinin bozulmasına ve hücre içi kalsiyum konsantrasyonunun artması sonucu bir 
sistein-proteaz olan kalpain enziminin patolojik olarak aşırı aktive olmasına sebep 
olmaktadır. Kalpainin aşırı aktivasyonunun ise nöronlarda hücre siklus aktivasyonu 
ve apoptoza sebep olan en önemli etkenlerden biri olduğu belirtilmektedir.  
Kalpainin patolojik olarak aktive olması nöronları direkt ya da dolaylı yoldan 
apoptoza sürüklemektedir. Dolaylı yol, kalpainin p35 adlı proteini p25 ve p10 olarak 
iki parçaya kesmesidir. Normal şartlarda, p35, CDK5 adı verilen ve nörona spesifik 
olup mitotik olmayan bir proteinin partneridir ve ikisi CDK5/p35 kompleksini 
oluşturarak nöronlarda farklılaşma ve göç gibi bir çok farklı görevde yer alırlar. 
Fakat, kalpainin aşırı aktivasyonu durumunda p35, kalpain tarafından p25 ve p10 
parçalarına ayrılır. p25 proteini de, p35 gibi CDK5 ile kompleks oluşturma özelliğine 
sahiptir. Fakat CDK5/p25 kompleksi, CDK5/p35 kompleksinden lokalizasyon ve 
fonksiyon bakımından farklılık gösterir. Normal şartlarda, hücre siklus aktivasyonu 
için gerekli olan kompleks Siklin D-CDK4 kompleksidir ve bu kompleks pRb 
proteinini fosforlayarak hücreleri G1/S geçişine hazırlar. Kalpain aşırı aktivasyonu 
durumunda ise, nöronlarda hücre siklus aktivasyonuna sebep olarak pRb proteinini 
fosforlayan kompleksin siklin D-CDK4 yerine CDK5/p25 kompleksi olduğu 
gösterilmiştir. Fakat bu hücre siklusuna giriş çabası başarısızlıkla sonuçlanmakta ve 
nöronlar p53 seviyesinde ve aktivitesindeki bir artış sonucu apoptoza gitmektedirler. 
Bunlara ek olarak, CDK5/p25 kompleksi p53 proteinini substrat olarak kullanıp 
doğrudan aktifleştirebilmektedir. Bütün bu veriler, kalsiyum ile aşırı aktive olan 
kalpainin nöronlarda hücre siklusunun yeniden aktivasyonuna sebep olduğunu, 
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ayrıca p53’ün ekspresyonunda ve aktivasyonunda bir artışa sebep olarak dejenere 
olan nöronları apoptoza sürüklediğini göstermektedir. 
İndirekt apoptotik etkisinin yanısıra, kalpain aynı zamanda p53’ü substrat olarak 
kullanıp direkt olarak indükleyebilmektedir. İndüklenen p53 mitokondriyal apoptotik 
sinyalleri ve kaspaz-3 aktivasyonunu tetikleyerek sonuçta kaspaz bağımlı apoptoza 
sebep olmaktadır. 
Siklinler, hücre siklusunun kontrolünde CDK’leri aktive eden ana elemanlar olmakla 
birlikte, SpeedyRINGO adı verilen başka bir protein de CDK’leri aktive edebilme 
özelliğine sahiptir. SpeedyRINGO’nun hücre siklusunun kontrolündeki rolünün 
yanısıra, bazı mitotik hücrelerde kaspaz-bağımlı apoptozu önlediğine dair çalışmalar 
da mevcuttur. 
SpeedyRINGO’nun temel görevi hücre siklusunun belirli noktalarda kontrolü 
olmakla birlikte, son yapılan çalışmalar bu proteine farklı bir görev yükleyerek, DNA 
hasarına uğramış mitotik hücrelerde anti-apoptotik olarak etkiye sahip olduğunu 
söylemektedirler. Bu çalışmalarda, SpeedyRINGO’nun, DNA hasarına uğramış 
U2OS adı verilen mitotik hücrelerde, p53 proteininin varlığına bağlı bir şekilde 
apoptozu engellediği, ayrıca UV ışıması gibi bir çok dış ve iç apoptotik faktöre karşı, 
kaspaz-3 aktivasyonunu engelleyerek, mitotik hücreleri koruduğu gösterilmiştir.  
Bütün bu verilerden yola çıkılarak, bu çalışmada esas olarak, nöronlarda kalpainin 
aşırı aktivasyonunun ortaya çıkardığı dejeneratif ve apoptotik etkilerinin, 
SpeedyRINGO proteinini nöronlarda eksprese ettirerek ortadan kaldırılması 
amaçlanmıştır.  
Bu amaçla, iki deney grubu oluşturulmuştur. Deney gruplarının birinde hipokampal 
nöronlarda kalsiyum iyonoforu ile sadece kalpain aktivasyonu yapılarak kalpainin 
aşırı aktivasyonunun nöronlarda meydana getireceği olası değişiklikleri gözlemlemek 
hedeflenmiştir. Diğer deney grubunda ise nöronlar öncelikle elektroporasyon 
yöntemi kullanılarak SpeedyRINGO ile transfekte edilmiş, ardından kalsiyum 
iyonoforu ve kalsiyum içeren bir medya yardımıyla hücre içi kalpainin indüklenmesi 
ve aşırı aktifleşmesi sağlanarak SpeedyRINGO’ nun nöronları kalpainin bu aşırı 
aktivasyonuna karşı koruyup koruyamayacağının araştırılması amaçlanmıştır. Daha 
sonra, her iki deney grubunda da farklı hücre siklus belirteçlerinin yanısıra CDK5, 
Siklin D1, p27, CDK2, p53 ve aktif kaspaz-3 mRNA ve protein seviyelerindeki 
değişimlerin karşılaştırmalı olarak araştırılması amacı ile, SpeedyRINGO’ nun 
dejenerasyona uğrayan  nöronlarda anti-apoptotik etki gösterip göstermediğini 
anlayabilmek için QRT-PCR, floresan boyama ve western blotlama teknikleri 
uygulandı.  
Çalışmanın sonuçlarına göre, kalpainin indüklendiği nöronlarda CDK5’ in mRNA ve 
protein seviyelerinde artış görülürken, Siklin D’ nin mRNA ve protein seviyelerinde 
belirgin bir artış bulunamamıştır. Bu sonuç da kalpain indüksiyonunun Siklin D 
yerine CDK5 üzerinden nöronlarda hücre siklus aktivasyonuna yol açtığını görüşünü 
desteklemektedir. Ayrıca, kalpain indüksiyonu sonucu nöronlarda p53 ün de 
indüklendiği ve miktarında artış olduğu ve sonrasında aktif kaspaz-3 seviyesinin de 
arttığı görülürken, öncelikle SpeedyRINGO’ nun eksprese edilip daha sonra 
kalpainin indüklendiği nöronlarda p53 artışı sabit kalırken, aktif kaspaz-3 artışının 
engellendiği görülmüştür. p53 proetininin varlığı, SpeedyRINGO proteininin kaspaz-
3 aktivasyonunu engellemesi için gerekli olduğundan bu, beklenen bir sonuçtur. 
Bütün bu bulgulara ek olarak, destekleyici bir diğer bulgu da hem DAPI boyaması 
hem de TUNEL analizi ile elde edilen ve nöronlardaki apoptoz seviyesini gösteren 
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sonuçlarından gelmektedir. Apoptoz analizleri göstermiştir ki, Kalpainin aşırı aktive 
edildiği nöronlar erken-apoptotik evrede bulunurken, önce SpeedyRINGO 
ekspresyonunun sağlandığı ve daha sonra kalpainin aşırı aktivasyonunun uyarıldığı 
nöronlarda hiç bir apoptotik belirti gözlemlenmemiştir. 
Sonuç olarak, nöronlarda kalpainin aşırı aktivasyonu sonrası p53 seviyesindeki artışa 
bağlı olarak ortaya çıkan kaspaz-3 aktivasyonunun SpeedyRINGO proteini 
tarafından engellenebildiği ve böylece nöronların kalpainin apoptotik etkisinden 
korunabildiği ilk kez bu çalışma ile gösterilmiştir. Bu çalışma, ileride 
SpeedyRINGO’ nun nörodejeneratif hastalıkların tedavisinde kullanılabilmesi için 
araştırmacılara yeni bakış açıları kazandırabilme potansiyeline sahiptir. 
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1.  INTRODUCTION 
1.1 Neurodegeneration 
The term “neurodegeneration” defines the progressive loss of function and structure 
of neurons that finally ends up with death of neurons.  
Neurons are terminally differentiated cells that have no mitotic activity. They are 
born far away from their area of function and they take a long journey migrating to 
their final destination in the nervous system. After reaching their target site, they 
complete their differentiation process and stop dividing by resting in quiescent (G0) 
phase (Lee, 2009) in order to use their microtubule based mitotic apparatus for 
axonal and dendritic branching rather than division (Baas, 1999). For this reason, 
under neurodegenerative conditions, neurons do not have the ability to regenerate 
themselves and go through programmed cell death. It implies that neurodegeneration 
is not a reversible process. 
There is a number of neurodegenerative diseases such as Alzheimer ’s disease, 
Parkinson ’s disease and Huntington ’s disease, which seriously affect millions of 
elderly population in the world.  
Although neurons are known to be non-dividing cells, recent studies have shown that 
under neurodegenerative conditions, there is an up-regulation of cell cycle regulatory 
proteins causing aberrant cell cycle re-entry in neurons (Herrup, 2010) which is 
accepted as one of the earliest pathological symptoms of most of the 
neurodegenerative diseases especially that of Alzheimer’s disease (Lee, 2009). In 
Alzheimer’s disease, degenerating neurons re-enter into cell cycle and even replicate 
their genomes, but they cannot complete mitosis and undergo apoptosis, since they 
do not have the mitotic machinery (Zhu, 2008; Herrup, 2010) (Figure 1.1).  
 
 
2 
 
 
Figure 1.1 : Schematic presentation of neuronal death (Herrup, 2010). 
1.1.1 Cell cycle re-activation in neurodegeneration 
Cell cycle is strictly controlled at numerous checkpoints allowing normal cell 
proliferation in mitotic cells when necessary. There are four phases of cell cycle: G1 
(Gap 1), S (DNA replication), G2 (Gap 2) and M (mitosis). G1 phase is known as 
“growing phase” in which a large number of proteins are synthesized that are 
necessary for DNA replication. S phase is the “DNA replication” phase and all the 
chromosomes are duplicated at the end of this phase. G2 is the phase in which 
especially microtubules that are required during mitosis are synthesized. Finally, M 
phase is the mitosis and cytokinesis phase in which duplicated chromosomes are 
separated into two identical sets in the nucleus. Then cytokinesis occurs and two 
daughter cells are generated (Cooper, 2000).  
Cylins and cyclin-dependent kinases (CDKs) are the key players of the mitotic cell 
cycle. Various cyclin/CDK complexes are sequentially activated in particular cell 
cycle phases to regulate the transition from one phase to the other. In response to 
extracellular mitotic signals, firstly Cyclin D is expressed and binds to CDK4 and 
forms active CyclinD-CDK4 complex. Active Cyclin D-CDK4 complex 
phosphorylates retinoblastoma protein (pRb). When pRb is hyper-phosphorylated 
(ppRb), it dissociates from E2F/DP1/Rb complex and activates E2F. Activated E2F 
causes transcription of numerous genes such as Cyclin A and Cyclin E. Then Cyclin 
E binds to CDK2 and forms active Cyclin E-CDK2 complex, which is responsible 
for G1/S transition of the cell. After that, Cyclin A forms an active complex with 
CDK2 that is required during S phase. In G2 phase of the cycle, Cyclin A binds to 
CDK1 in order to activate some transcription factors for the synthesis of necessary 
proteins for M phase. Finally, Cyclin B binds to and forms an active complex with 
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CDK1 initiating the G2/M transition. This complex also takes role in nuclear 
envelope breakdown at the beginning of prophase (Cooper, 2000; Dehay, 2007) 
(Figure 1.2).  
 
Figure 1.2 : Different phases of the cell cycle (Dehay, 2007). 
On the other hand, arrest of cell cycle event is highly controlled by an increase in the 
concentration of CDK inhibitors in neurons, since they are post-mitotic cells. 
However, there are studies indicating that mitotic cyclins and CDKs are still present 
in adult neurons. These finding is contradictory to the widely known feature of 
neurons that they do not have the mitotic ability. Compared to mitotic cells, only 
difference is that localization of mitotic proteins is switched from nucleus to the 
cytoplasm in adult neurons (Schmetsdorf, 2005). Thus, these results support the idea 
that the functions of mitotic regulators are switched to neuronal survival in the post-
mitotic neurons. It is believed that all mitotic players have alternative functions in 
neurons such as neuronal plasticity (Frank, 2009; Schmetsdorf, 2005). 
In addition, there are some studies showing the inactivation of CDK inhibitors in 
case of Alzheimer’s disease indicating that if necessary, these CDK inhibitors could 
not function to stop any cell cycle re-activation (Nagy, 2001).  
Although the classic view still holds that terminally differentiated neurons, which 
remain in G0 phase, are unable to re-enter into the cell cycle, a growing body of 
evidence has demonstrated the up-regulation of mitotic cell cycle regulatory proteins 
in case of neurodegeneration especially in that of Alzheimer ’s disease brain (Nagy, 
2001; Yang, 2007).  
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The exact mechanism and starting point of neurodegeneration in case of Alzheimer’s 
disease are not well known, but some of the studies showed that cell cycle re-entry 
precedes some other pathological hallmarks of Alzheimer’s disease such as tau 
hyper-phosphorylation. Thus, it is thought that cell cycle re-entry could be the 
starting point for development and progression of Alzheimer’s disease pathology 
(Vincent, 1998). 
Neurons have been shown to activate their cell cycle leaving G0 phase and going into 
G1 due to a number of neurotoxic conditions such as amyloid beta aggregation, 
metabolic alterations, oxidative stress (Herrup, 2004) (Figure 1.3). However, there is 
no evidence that neurons successfully complete mitosis. This indicates that activated 
cell cycle is arrested at one of the checkpoints before passing through mitosis. 
Therefore, this amateur cell cycle activation attempt leads neurons into apoptosis 
(Park, 2007; Federsen, 1992).  
 
Figure 1.3 : Illustration of cell cycle re-activation in degenerating neurons (Herrup, 
2004). 
Amyloid beta aggregation, a hallmark of Alzheimer’s disease, causes destabilization 
of calcium homeostasis and results in the elevation of intracellular calcium levels, 
which finally leads to pathological activation of a calcium-sensitive cysteine-
protease, calpain. Calpain over-activity is known to be one of the most important 
factors causing cell cycle re-activation and degeneration in neurons (Nakamura, 
1997; Araujo, 2004).  
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1.2 Calpain 
Calpains are known as calcium-activated proteolytic enzymes (Harris, 2004). There 
are almost 15 types of calpains identified, but two isoforms, ì-calpain (calpain I) and 
m-calpain (calpain II), are especially found in mammalian tissues (Yadavalli, 2004). 
The difference between two isoforms is the calcium sensitivity that ì-calpain is 
activated at micromolar per liter levels, while m-calpain is activated at milimolar per 
liter levels of calcium. In its inactive proenzyme form, calpain is found in the 
cytoplasm, and is activated in the presence of high levels of calcium (Camins, 2006).  
1.2.1 Structure and activation of calpain 
Both isoforms of calpain are heterodimers, which are composed of a large 80 kDa 
catalytic subunit and a small 30 kDa regulatory subunit. 30 kDa regulatory subunit is 
identical in the same tissue type or animal species but 80 kDa subunit is specific and 
not identical. The large 80 kDa subunit is composed of four domains. Domain I is the 
autolytic cleavage site, domain II has the cysteine protease activity and interacts with 
the substrates. Domain III does not have a known function. Domain IV contains E-
helix-loop-F-helix motifs (EF hands) on which are calcium binding sites (Neumar, 
2003) (Figure 1.4). 
The small 30 kDa subunit contains two domains: V and VI. Domain V is the terminal 
domain and possesses glycine residues, while domain VI has five EF-hand calcium 
binding motifs (Yang, 2004; Swapan, 2003) (Figure 1.4). 
 
Figure 1.4 : Structural domains of calpain subunits (Swapan, 2003). 
 
6 
 
Calpain is localized in the cytosol in its inactive form in the absence of calcium. 
When there is an increase in intracellular calcium levels, calpain is translocated to 
the membrane and there, it becomes activated with calcium and phospholipids. 
Calpain activation occurs mainly in two stages. In inactive form, two subdomains of 
protease domain II (IIa and IIb) are separated by structural constraints. In the first 
stage of activation, this structural constraint is released in the presence of calcium 
ions, which is a necessity to activate the calpain and to form the active catalytic site 
(Moldveanu, 2002). Calcium binds to EF-hand motifs in domains III, IV and VI and 
this binding separates domain II from domain III. Therefore, 30 kDa subunit 
dissociates from 80 kDa subunit at the end of first stage. At the second stage, active 
site on the protease domain II is rearranged to be able to interact with its substrates 
(Reverter, 2001) (Figure 1.5). 
 
Figure 1.5 : Calpain activation mechanism by calcium (Suzuki, 2004). 
Activated calpain has a number of substrates such as growth factor receptors, 
cytoskeletal proteins, microtubule- associated proteins and mitochondria to be able to 
play crucial roles in different cellular mechanisms such as progression of cell cycle 
(Jánossy, 2004), differentiation, apoptosis and long-term potentiation in neurons 
(Vanderklish, 1996; Sorimachi, 1997). 
Calpain activity is strictly regulated mainly by calcium, since it has many vital 
cellular functions and hence deregulation of calpain activity can cause serious 
pathological conditions ending up with the death of the cell (Suzuki,2004).  
On the other hand, there is an endogenous inhibitor of calpain, namely calpastatin 
which regulates the activity of ì- and m-calpain (Polster, 2005) It reversibly binds to 
the active site and inhibits calpain only in the presence of calcium ions (Hanna, 
2008). 
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Recent studies have indicated that calpains play a significant role in the cell cycle re-
activation and the apoptotic processes in case of neurodegeneration (Liou, 2005). 
Deregulation of calcium homeostasis results in calcium overload and subsequent 
calpain over-activation can force neurons to re-enter into cell cycle and ultimately 
undergo apoptosis. 
1.2.2 Role of calpain in neurodegeneration 
Calpain is known to be one of the most effective proteins of which deregulation leads 
neurons into apoptosis through different pathways (Liou, 2005).  
Calpain induction and over-activation drive neurons into apoptosis directly or 
indirectly. Indirect way is the cleavage of p35 protein into p25 and p10 fractions by 
calpain. Under normal conditions, p35 is the partner for CDK5, which is a non-
mitotic neuron-specific kinase, and by forming CDK5/p35 complex, they take place 
in important cellular events such as neuronal development and maturation 
(Dhariwala, 2008; Yip, 2007; Fu, 2006). However, in case of neuronal calpain over-
activation, calpain cleaves p35 into p25 and p10 fractions, since p35 is a substrate of 
calpain. p25 has binding ability to CDK5 to form CDK5/p25 complex. However, this 
complex differs from CDK5/p35 complex in terms of localization and functions 
(Cruz, 2004). Normally, Cyclin D-CDK4 complex is required for cell cycle 
activation and it is responsible for G1/S transition by phosphorylating pRb protein, 
but in case of calpain over-activation in neurons, it was shown that CDK5/p25 
complex phosphorylates the pRb protein instead of Cyclin D-CDK4 complex and re-
activates cell cycle driving neurons through G1/S transition (Hamdane, 2005; Alvira, 
2008) (Figure 1.6). However, this mitotic re-entry cannot be successfully completed 
and neurons undergo apoptosis by an increase in p53 levels. Another important 
finding is that CDK5/p25 complex can directly activate p53, since p53 is a substrate 
for CDK5 (Zhang, 2002). All these findings strongly indicate that calcium-mediated 
calpain activation ends up with an increase in p53 expression and activation, and 
therefore subsequent caspase-dependent apoptosis in degenerating neurons. 
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Figure 1.6 : Schematic representation of apoptotic pathways generated by 
CDK5/p25 complex (Camins, 2006). 
Direct way for calpain forcing neurons go through apoptosis is that p53 is the 
substrate of calpain itself and hence, calpain over-activation directly leads to 
increased p53 expression and activation. Induced p53 triggers mitochondrial death 
signals and caspase-3 activation ultimately resulting in caspase-mediated apoptosis 
(Sedarous, 2003).  
In addition, experimental data suggest some neuroprotective effects for inhibitors of 
calpain and caspase in neurons (O’Hare, 2005; Raghupati, 2004). An increased body 
of evidence indicates an interaction between calpain and caspase proteolytic systems. 
Calpain can lead to activation of caspase-3 by cleaving pro-caspase-3. Caspases can 
also take role in degradation process of the specific endogenous calpain inhibitor, 
calpastatin accelerating calpain activation. Moreover, in an experiment using 
ultraviolet radiation to trigger apoptosis, it was shown that calpain activity is required 
for caspase-3 activation (Maccioni, 2001). These findings obviously indicate that 
both calpain and caspase proteolytic systems are involved in progression of neuronal 
death (Sharma, 2004).  
Since calpain over-activity is one of the most important neurodegeneration factors 
causing both cell cycle re-activation and the activation of apoptotic machinery as 
explained in detail above, it was crucial to find a way to regulate this cell cycle re-
activation attempt and to prevent calpain-mediated apoptosis in degenerating 
neurons.  
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As neurons left their dividing ability, cell cycle re-activation is a rather chaotic 
attempt and ultimately leads neurons to apoptosis. For this reason, it was important to 
identify how SpeedyRINGO, a novel cell cycle regulatory protein, would be 
effective on positive regulation of this chaotic cell cycle re-activation in calpain 
over-activated neurons.  
Cell cycle progression is strictly controlled by CDKs, which form complexes with 
distinct cyclins according to the different phases of the cell cycle. Although, cyclins 
are major players, which take role in activation of CDKs, there is another protein, 
SpeedyRINGO that can activate CDKs. Besides its role in cell cycle regulation, 
SpeedyRINGO has also been shown to have another important function in preventing 
caspase-dependent apoptosis in mitotic cells (McAndrew, 2009). 
1.3 SpeedyRINGO Protein 
Cell cycle progress is strictly controlled by CDKs in eukaryotic cells. Activities of 
CDKs are regulated mainly by cyclins. Cyclins bind, phosphorylate and activate 
different CDKs during different phases of the cell cycle. Although cyclins are main 
players in regulating CDKs activity, there is a novel protein, named SpeedyRINGO 
(Rapid Inducer of G2/M progression in Oocytes) that can bind and regulate the 
activity of CDKs in many types of eukaryotic cells (Cheng, 2005).  
SpeedyRINGO is a novel cell cycle regulatory protein that was first identified in 
Xenopus oocytes as a regulator of the meiotic cell cycle that accelerates G2/M 
progression during maturation of oocytes (Nebreda, 2006). Resting oocytes are found 
at the G2/M of the first meiotic division. Progesterone is the stimulating factor to 
overcome this G2/M arrest and allow oocytes go through meiosis by inducing mos 
protein expression which is a proto-oncogene product that takes role on G2/M 
progression (Lenormand, 1999). However, it has been reported that a novel gene 
product of Xenopus, named SpeedyRINGO, is sufficient to stimulate and accelerate 
G2/M progression and meiotic maturation. It has also been shown that the rate of 
SpeedyRINGO- mediated meiotic maturation is faster than that of progesterone and 
mos. SpeedyRINGO has been shown to induce meiotic maturation independent of 
mos (Lenormand, 1999).  
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SpeedyRINGO binds and activates CDKs, although it has no sequence similarity to 
cyclins (Cheng, 2005). Unlike cyclins, SpeedyRINGO activates CDKs by a 
phosphorylation-free mechanism, which is not well known yet.  
There are mainly three branches of SpeedyRINGO family: SpeedyRINGO A, B, C 
and a suspected fourth SpeedyRINGO D. The most conserved branch is 
SpeedyRINGO A, which appears to be the most slowly evolving and ancient branch 
of SpeedyRINGO family. It has been shown to be found in fish, chicken, sea urchin 
and mammals in nearly all types of cells (Cheng, 2005). In mammals, SpeedyRINGO 
A has been shown to have higher expression levels in testis and lower expression 
levels in other tissues such as brain, heart, lung, placenta, prostate, small intestine 
etc. 
SpeedyRINGO B is the least conserved branch of SpeedyRINGO family. It has been 
shown to be expressed in testis of only mammals (Cheng, 2005).  
SpeedyRINGO C is structurally similar to SpeedyRINGO A and it has been shown to 
be especially expressed in certain cell types belonging to such as liver, bone marrow 
and placenta tissues implying that it could be responsible for polyploidization in 
these tissues (Cheng, 2005).  
All SpeedyRINGO family members have a central region called SpeedyRINGO box, 
which is conserved among all SpeedyRINGO proteins. This SpeedyRINGO box has 
been shown to be required for CDK binding, but not for activating (Figure 1.7, 
Figure 1.8) (Cheng, 2005). 
 
Figure 1.7 : Structural domains of SpeedyRINGO homologues, Xenopus 
SpeedyRINGO (xSpeedyRINGO), SpeedyRINGO A, SpeedyRINGO 
B, SpeedyRINGO C and SpeedyRINGO D showing the conserved 
SpeedyRINGO box region. 
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Figure 1.8 : Alignment of the conserved SpeedyRINGO boxes of human 
homologues SpeedyRINGO A, SpeedyRINGO B and SpeedyRINGO C 
using Basic Local Alignment Search Tool (BLAST) of National Center 
for Biotechnology Information (NCBI). 
In this study, human SpeedyRINGO homologue, Spy1 was used. It is a 
SpeedyRINGO A family member and located on chromosome 2 at location 2p23.2. 
There are three identified regions of Spy1: a CDK binding site, which is, known as 
SpeedyRINGO box, a C-terminal CDK activation site and an N-terminal site affects 
the expression of Spy1. SpeedyRINGO box is required for CDK binding and alanine 
scanning mutagenesis studies showed that conserved feature of the box is essential 
for CDK binding (Cheng, 2005). However, SpeedyRINGO box is not sufficient for 
CDK activation on its own. C-terminal region has been shown to be essential for 
CDK activation. The function of N-terminal is not well known, but it has been shown 
to negatively regulate the expression of SpeedyRINGO itself. This negative 
regulation may keep SpeedyRINGO under strict control to avoid disruption of CDK-
regulatory pathways, since SpeedyRINGO could activate different CDKs 
prematurely (Cheng, 2005). 
Spy1 has been shown to be widely expressed in mitotic cells and cell lines and it has 
been shown to be required for S phase entry in somatic cells (Porter, 2002). CDK2 is 
the specific partner of Spy1 indicating that its activity is CDK2-dependent (Porter, 
2002). In mitotic cells, over-expression of SpeedyRINGO binds and activates CDK2 
leading to phosphorylation and degradation of p27
kip 
and, consequently, accelerating 
G1/S phase progression and cell division. However, SpeedyRINGO-CDK2 complex 
has been shown to have low enzymatic activity against conventional CDK2  
substrates implying that SpeedyRINGO-CDK2 is unlikely to regulate cell cycle 
progression on its own (McAndrew, 2007; Gastwirt, 2006 ). 
1.3.1 Role of speedyRINGO in the inhibition of apoptosis 
When there is any damage to DNA as a result of an apoptotic action during cell 
cycle, cells initiate cell cycle arrest by activating checkpoint responses to provide 
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enough time to cell for repairing the genome (Bartek, 2007). In case of encountering 
un-repairable DNA, cells activate their apoptotic machinery, which ultimately results 
in the death of cells. p53 is the key player that is induced in response to any DNA 
damage. Induction of p53 expression and activation results in DNA damage 
checkpoint response activation (Attardi, 2005). 
Although SpeedyRINGO mainly functions in cell cycle regulation in mitotic cells, 
recent studies have also attributed a different role for SpeedyRINGO that it has an 
anti-apoptotic effect in DNA-damaged mitotic cells and hence allow cell survival 
(McAndrew, 2009). It has been shown that SpeedyRINGO prevents apoptosis in a 
p53-dependent manner  in response to DNA damage in U2OS cells, which is a 
mitotic human osteosarcoma cell line (McAndrew, 2009). SpeedyRINGO was 
indicated to have strong survival effect in mitotic cells that encountered a number of 
extrinsic or intrinsic apoptotic factors such as UV irradiation. SpeedyRINGO fulfills 
this function by inhibiting caspase-3 activation and apoptosis in the presence of the 
gene regulatory protein p53 (McAndrew, 2009; Gastwirt, 2006).  
Although exact mechanism of this anti-apoptotic effect is not known, it is thought 
that SpeedyRINGO expression allows the cells to bypass the S-phase/replication 
checkpoint and the G2/M checkpoint. As a result of bypass of these checkpoints, 
cells cannot sense the DNA damage accumulation and hence do not arrest replication 
(Gastwirt, 2006).  
1.4 Aim of the Study 
Calpains are known as calcium-activated proteolytic enzymes. Activated calpain has 
a number of substrates such as growth factor receptors, cytoskeletal proteins, 
microtubule- associated proteins and mitochondria to be able to play crucial roles in 
different cellular mechanisms such as progression of cell cycle, differentiation, 
apoptosis and long-term potentiation in neurons. 
Although there are some intrinsic mechanisms regulating calcium influx in neurons, 
a number of neurotoxic conditions such as oxidative stress and amyloid beta 
aggregation cause deregulation of calcium homeostasis by increasing calcium influx 
into neurons. This abnormal level of calcium increase induces calpain and results in 
pathologic calpain over-activation. Over-activation of calpain has been known to be 
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one of the most important neurodegenerative factors both causing cell cycle re-
activation through CDK5 and apoptosis by inducing p53 and caspase-3 activation.   
SpeedyRINGO, a novel cell cycle regulatory protein, has been shown to bind and 
activate CDKs with a phosphorylation-free mechanism. In addition to its regulatory 
function, there is also another attributed function for SpeedyRINGO in preventing 
apoptosis by inhibiting caspase-3 activation in the presence of p53 in mitotic cells. 
Thus, utilizing SpeedyRINGO in non-mitotic neurons for its cell cycle regulatory 
and anti-apoptotic feature could be helpful for preventing calpain-based - caspase-
dependent apoptosis. 
Therefore, the aim of this study was to regulate chaotic cell cycle re-activation 
attempt with SpeedyRINGO, a novel cell cycle regulator, in calpain-based 
neurodegeneration, and also to prevent the apoptotic effect of calpain in degenerating 
neurons using SpeedyRINGO as an inhibitor of caspase-3 activation. For this 
purpose, hippocampal neurons are transfected with SpeedyRINGO and then, calpain 
was induced by calcium ionophore. After that, analysis was performed to see if 
SpeedyRINGO may have a regulatory effect on calpain-mediated cell cycle re-
activation attempt and also to identify if SpeedyRINGO may protect neurons against 
caspase-dependent apoptosis in the presence of p53. Results of this study may 
contribute towards understanding the survival effort of neurons against calpain-based 
neurodegeneration. 
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2.  MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Equipment 
The equipment used in the study is given in the Table 2.1: 
Table 2.1 : Equipment. 
Equipment Supplier Company 
Electrophoresis Gel System  E-C Apparatus Corporation, EC250-90 
Minicell Primo 
Power supply  EC250-90 Apparatus Corporation 
Thermal Cycler  
 
Applied Biosystems, GeneAmp PCR 
System 2700 
Microcentrifuge  Beckman Coultier 
Water Bath  
  
Memmert 
UV Transilluminator  ioRad UV Transilluminator 2000 
UVIPhotoMW Version 99.05 for Windows 95 
& 98 
 
UVItec Ltd. 
Shaker  Forma 
pH Meter  Mettler Toledo MP220 
Precision weigher  Precisa 620C SCS 
Vortex  Heidolph, Reaxtop 
Centrifuges  
 
Biolab SIGMA 6K15, Beckman Coulter 
Microfuge®18, Beckman Coulter AvantiTM J-30 I, 
IECCL10 Centrifuge, 
Thermo Electron Corporation, Labnet, Labnet International 
C1301-230V 
Magnetic stirrer  Labworld Standard Unit 
Microwave  Arçelik MD582 
Ice machine  Scotsman AF 10 
Laminar air flow cabinets  FASTER BH-EN 2003 
Incubator with CO2  Biolab SHEL LAB 
Inverted light microscope  Olympus CK40 
SDS-PAGE gel electrophoresis 
system  
BIO-RAD MiniProtean 
Power supply  Thermo Electron Corporation 
EC250-   90 
Freezers  
 
UĞUR (-20oC), UĞUR (+4 oC), 
New Brunswick Scientific (-80 oC) 
Tissue culture dishes 34 mm, TPP 
Cell scraper  30cm, TPP 
Hemacytometer  Fisher Scientific 
Serological pipette  TPP 
Nitrocellulose membrane Santa Cruz 
3MM Whatman filter paper  Whatman 
QRT-PCR equipment Roche Light Cycler 480 
Confocal microscope Leica TCP SP2 SE  
Electroporator Amaxa Nucleofector® Device, Lonza 
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2.1.2 Chemicals and enzymes 
Chemicals and enzymes used in this study are given in the Table 2.2: 
Table 2.2 : Chemicals and enzymes. 
Material Supplier Company 
Hank's Balanced Salt Solution 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid 
trypsin 2.5 % 
Neurobasal Medium 
B27 Supplement 
Alexa Fluor® 647 goat anti-rabbit IgG 
Alexa Fluor® 488 goat anti-mouse IgG 
Alexa Fluor® 647 donkey anti-rabbit 
SeeBlue Plus2 Prestained Protein Ladder 
 
 
 
 
Invitrogen 
Penicillin/Streptomycin 
45% D-Glucose 
DNase 
poly-L-Lysine 
A23187 Calcium
 
ionophore 
Methanol 
Donkey serum 
Bovine Serum Albumin 
Phophate Buffered Saline 
Tween20 (P9416) 
Ampicillin 
 
 
 
 
Sigma-Aldrich 
L-Glutamine 
Fetal bovine serum 
Goat serum 
 
Biological Industries 
 
CytoBuster
TM
 Protein Extraction Reagent  
Calbiochem 
Rattus norvegicus Cdk5 qRT-PCR probe 
Rattus norvegicus CyclinD1 qRT-PCR probe 
Rattus norvegicus Cyclin-dependent kinase 
inhibitor 1B (p27
kip
) qRT-PCR probe 
Rat ACTB Gene Assay 
Rat GAPD Gene Assay 
T4 DNA Ligase 
10X T4 Ligase buffer 
 
 
 
 
Roche 
pIRES expression vector Clontech Lab. 
Rabbit polyclonal IgG anti-CyclinD1 antibody 
Mouse monoclonal IgG anti-CDK5 antibody 
Mouse monoclonal anti-actin antibody 
Mouse monoclonal anti- p27
kip 
antibody 
 
 
 
Santa Cruz 
Mouse monoclonal IgG anti- beta- III- tubulin 
antibody 
Anti-HRP secondary antibodies 
 
Promega 
Rabbit polyclonal IgG anti-SpeedyRINGO 
antibody 
 
Affinity Bioreagents 
Mouse monoclonal anti-CDK2 antibody Biosource 
Mouse monoclonal anti-p53 antibody 
Rabbit monoclonal anti-caspase-3 antibody 
 
Cell Signaling Tech. 
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Table 2.2 (continued) : Chemicals and enzymes. 
Material                                                 
Taq polymerase  
dNTP Mix        
10x PCR buffer 
Nhe I restriction enzyme 
EcoR I restriction enzyme 
MassRuler™ DNA Ladder (Mix, 80bp-10Kb) 
10X Tango Y buffer 
25 Mm MgCl2 
6X Loading dye 
Supplier Company 
 
 
 
Fermentas 
Low melting agarose 
TEMED 
AppliChem 
Tryptone  Lab M TM 
PIPES 
Tris Base 
Acrylamide 
 
BDH Laboratory 
DMSO 
Acetone 
Absolute ethanol 
 
Riedel- de Haёn 
Diethyl ether  LACHEMA 
Glysin 
APS 
CaCl2.2H2O 
EDTA 
SDS 
Glucose 
Ethidium bromide 
Yeast Extract 
Agar 
KCl 
DTT 
HCl 
 
 
 
 
 
Merck 
MgCl2.6H2O 
NaCl 
Carlo Erba 
Isopopanol 
Glycerol 
PEG 8000 
Glacial Acid 
 
Fluka 
2.1.3 Commercial kits 
Commercial kits used in this study are given in the Table 2.3: 
Table 2.3 : Commercial kits. 
Kit Supplier Company 
Fluorogenic Calpain Activity Assay Kit Calbiochem 
Bicinchoninic acid (BCA) protein assay kit Pierce 
High Pure RNA Isolation Kit 
Light Cycler
®
 480 Probes Master qRT-PCR Kit 
Cytotoxicity Detection Kit 
 
Roche 
Quant-iT™ RNA, BR Assay Kit Invitrogen 
RevertAid™ H Minus First Strand cDNA 
Synthesis Kit 
Fermentas 
Mammalian Cell Extraction Kit Biovision 
ECL Plus Western Blotting Detection Kit GE Healthcare 
QIAquick PCR purification kit  Qiagen 
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2.1.4 Buffers and solutions 
2.1.4.1 TAE buffer (50X) 
TAE Buffer (50X) was prepared as a mixture of 20 mM glacial acetic acid, 40 mM 
Tris base and 1 mM EDTA (pH 8.0) in dH2O. 
2.1.4.2 2X sample buffer for SDS-PAGE 
2X sample buffer was used to denature protein samples before loading on SDS 
polyacrylamide gel. 2X sample buffer was prepared by dissolving 2 ml (100%) 
glycerol, 5 mg bromophenol blue, 4 ml (10%) SDS, 2.5 ml (0.5 M) tris-HCL and 231 
mg DTT in 10 ml ddH2O. 
2.1.4.3 Tris buffer saline (TBS) 
Tris buffer saline (TBS) was prepared as 10X stock solution by dissolving 12.1 g 
Tris and 87.66 g NaCl in 1 lt ddH2O and then pH was adjusted to 8.0. 1X Working 
solution was prepared by diluting 10X TBS by 10 times.  
2.1.4.4 Tris buffer saline – Tween20 (TBS-T) 
Tris buffer saline – Tween20 (TBS-T) is the washing buffer used in all western blots 
in this study. TBS-T was prepared by dissolving 0.1% (v/v) Tween20 in 1X TBS.  
2.1.4.5 Towbin buffer 
Towbin buffer is the transfer buffer that was used in all western blots in this study. 
Towbin was prepared by dissolving 20% (v/v) Methanol, 7.5g (192 mM) Glycine 
and 1.5 g (25 mM) Tris in 500 mL ddH2O. 
2.1.4.6 Blocking buffer for immunofluorescence analysis 
Blocking buffer is used to avoid non-specific binding of the antibody. To prepare 1 
mL  blocking buffer 10 mg (10 mg/mL) BSA and 100 µl (10%) Goat or Donkey, 
(depending on the type of secondary antibody) serum were mixed in 1X PBS and 
filtered with 0.8µm Nalgene filter in order to prepare 1 mL blocking buffer. 
2.1.4.7 Blocking buffer for western blotting 
5 g (5%) skim milk and 1 g (1%) BSA were dissolved in 1X TBS in order to prepare 
100 mL western blocking buffer. 
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2.1.4.8 Stripping buffer for western blotting 
200 mM Glycine was dissolved in ddH2O and then pH was adjusted to 2.5 with HCl 
in order to prepare 100 mL western stripping buffer. 0.5% Tween20 was  added into 
glycine solution before use.  
2.1.4.9 Calcium-containing medium 
Calcium-containing medium was used for calpain activation study. It was prepared 
by dissolving 5.6 mg KCl, 1.215 mg CaCl2, 250 µl HEPES, 128,4 mg Sucrose, 203 
mg NaCl and 50 µl Glucose in 25 ml dH2O. 
2.1.4.10 Calcium ionophore 
Calcium ionophore (1mg/ MW=523.6) was dissolved in 19.1 µl DMSO to prepare 
100 Mm stock solution. Then 200 µM working solution was prepared from the stock 
solution in dH2O. 
2.1.5 Bacterial strain 
Escherichia coli (E.coli) DH5α strain [F-, φ80dlacZ_M15, _(lacZYA-argF)U169, 
deoR, recA1, endA1, hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1], 
Invitrogen. 
2.1.6 Bacterial culture media 
2.1.6.1 LB medium 
To prepare 1 L of LB medium, 10 gr tryptone, 5 gr yeast extract and 10 gram NaCl 
were dissolved in ddH2O. Then LB medium was sterilized by 15 minutes 
autoclaving. A final concentration of 50 µg/ml of ampicillin was added to the LB 
medium to make the selective media for pIRES expression vector that was used in 
the study. Ampicillin containing LB was stored at 4ºC. 
2.1.6.2 LB-agar plate 
15 gram/L of agar was mixed with LB medium and 15 minutes-sterilized by 
autoclaving. After cooling of LB-agar, it was poured into several plates. 
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2.1.6.3 SOC medium 
To prepare 100 mL SOC medium, 5 gr of yeast extract, 2 gr of tryptone, 0.0186 gr of 
KCl, 0.058 gr of NaCl, 0.095 gr of MgCl2, 0.36 gr of glucose and 0.24 gr of MgSO4 
were dissolved in ddH2O. Then prepared SOC medium was autoclaved for 15 
minutes at 120°C. Before use, antibiotic was added to make the medium selective. 
SOC medium was used to cultivate E.coli after temperature shocking during 
transformation.  
2.1.7 pIRES expression vector 
pIRES is a mammalian expression vector, which enables high level expression of 
two genes of interest from the same mRNA. pIRES is comprised of the 
encephalomyocarditis virus (ECMV) internal ribosome entry site (IRES) flanked by 
two multiple cloning sites (MCS A and B). pIRES also contains a partially disabled 
IRES sequence that decreases the translational rate of the gene, which is cloned into 
MCS B relative to that of MCS A.  
The constitutively active cytomegalovirus immediate early promoter (PCMV IE), 
located upstream of MCS A, regulates the transcriptional expression of the desired 
gene. In between PCMV IE and MCS A is an intervening sequence (IVS) that 
promotes the stability of mRNA. IVS is spliced out after transcription. SV40 
polyadenylation signals downstream of MCS B control proper processing of the 3' 
end of the mRNA. Bacteriophage T3 and T7 promoters are located downstream of 
MCS B and upstream of MCS A, respectively. In the vector, there is also an 
ampicillin resistance gene (Ampr), and a ColE1 origin of replication for selection and 
propagation in E. coli, and an f1 origin for single-stranded DNA production. 
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Figure 2.1 : pIRES vector map (A) and Multiple cloning site of pIRES (B). 
2.1.8 Primary hippocampal neuron culture media 
2.1.8.1 Hippocampus dissection medium 
In order to prepare 100 mL hippocampus dissection medium, 10 mL HBSS, 1 mL 1 
M HEPES and 1 mL Penicillin-Streptomycin were dissolved in 88 mL ddH2O. 
Medium was sterilized with 0.2 µm filter (Nalgene).  
2.1.8.2 Hippocampal plating medium  
Hippocampal medium was used for washing hippocampi pieces during dissection 
procedure. In order to prepare 50 mL hippocampus plating medium, 1 mL B27 
Supplement, 0.33 mL 45% D-Glucose, 0.25 mL L-Glutamine and 2.5 mL FBS were 
mixed in 45.92 mL Neurobasal medium. Medium was sterilized with 0.2 µm filter 
(Nalgene).  
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2.1.8.3 Hippocampal serum free plating medium 
In order to prepare 50 mL hippocampus serum free plating medium, 1 mL B27 
Supplement, 0.33 mL 45% D-Glucose and 0.25 mL L-Glutamine were dissolved  in 
48.42 mL Neurobasal medium. Medium was sterilized with 0.2 µm filter (Nalgene).  
2.1.9 Experimental animals 
Post-natal 0 (PN0) Sprague-Dawley rats were used for hippocampal neuron 
culturing. All the animals were handled according to appropriate animal care and 
utilization procedures. Ethical approval was obtained from the local scientific ethical 
committee. The procedures involving experimentation on animal subjects are done in 
accordance with both the guide of the local authorities and with the National 
Research Council's guide for the care and use of laboratory animals. 
2.2 Methods 
2.2.1 Subcloning of speedyRINGO into pIRES expression vector 
2.2.1.1 Primer design 
First, SpeedyRINGO was subcloned from pCS3 vector into pIRES expression vector. 
In order to subclone SpeedyRINGO (AY820303 / Homo sapiens speedy A isoform 1 
complete cDNA) from pCS3 vector into pIRES, first, SpeedyRINGO was cloned out 
from pCS3 by PCR using primers that were specifically designed for SpeedyRINGO 
(Figure 2.2). All the primers were designed by adding restriction sites on their 5’ 
ends. These restriction sites were then used for pIRES-SpeedyRINGO ligation 
studies. Designed primers are as in the Table 2.4: 
Table 2.4 : Designed primers for PCR reaction. 
Primer Sequence 
 
Forward primer 
(Nhe I restriction site added) 
5’ AAAAAGCTAGCATGAGCCACAATCAGATGTG 3’ 
Primer conct.: 116,865 nmole, Tm: 60,9 0C 
Reverse primer 
( EcoR I restriction site added) 
 
5’ CCGGAATTCCGGCTAAATCATACCTTCAGAACCA 3’ 
Primer conct.: 82,349 nmole,    Tm: 63,9 0C 
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Figure 2.2 : Demonstration of primer sequences on SpeedyRINGO cDNA sequence. 
2.2.1.2 Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) is a technique that is used to amplify a DNA region 
easily. This technique allows producing millions of copies of a DNA strand using 
enzymatic replication. Primers which are short oligonucleotides that are identical of 
nucleotide sequences on both side of the DNA strand of interest are required for PCR 
These primers provide DNA binding site for DNA polymerases. 
There are three main steps in a PCR cycle: denaturation, annealing and DNA 
synthesis. In the first step, the target DNA is denatured by heating to 90-96°C to 
unwind the strands. In annealing step, primers bind to their complementary 
sequences on the target DNA according to the specified annealing temperature of 
primers. The last step is the synthesis of DNA by DNA polymerase at a particular 
extension temperature. The polymerase reads the DNA strand starting from the 
primer sequences and couples it with complementary bases very easily. As a result, 
there are two new helices instead of one, each one is the copy of the original DNA 
strand. After designing primers, SpeedyRINGO was cloned out from pCS3 vector by 
using these primers. PCR Reaction Mixture was prepared as in the Table 2.5: 
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Table 2.5 : PCR reaction mixture. 
Ingredient Final Concentration 
pCS3-SpeedyRINGO construct(template)(1mg/ml) 1µg 
Forward primer (20 µM stock) 0,4 µM 
Reverse primer (20 µM stock) 0,4 µM 
Taq polymerase (5 U/µl) 2.5 U 
dNTP Mix       (10 mM) 5 mM 
10x PCR buffer 1x 
Water up to 25 µl 
PCR reaction was performed according to the following program in the Table 2.6 : 
Table 2.6 : PCR reaction conditions. 
 Temperature (
0
C) Time  
İnitial denaturation 94 2 min. 
Denaturation 94 45 sec. 
Annealing 59                 30 sec.  35 cycles                    
Elongation 72 1 min 
Final extension 72 10 min 
Final hold 4 +∞ 
2.2.1.3 Agarose gel electrophoresis 
Electrophoresis is used to separate molecules based on their certain properties, for 
instance, their size for DNA molecules. Since DNA is negatively charged, in electric 
field, it would migrate towards the positive pole through agarose-made sieve of 
molecular proportions. As a result, large DNA fragments move slower than the 
smaller ones. If the gel is stained with ethidium bromide after running process, 
migrated DNA can be visualized under ultraviolet light. 
To prepare 1% agarose gel, 0.4 g of low melting point agarose was dissolved in 40 
ml 1x TAE (Tris-acetate-EDTA) buffer. The agarose was then solubilized in a 
microwave oven until the agarose was completely dissolved. After that, agarose gel 
was cooled to 45ºC and ethidium bromide was added to a final concentration of 0.5 
g/ml and mixed gently. The agarose gel was then poured into a horizontal gel tray to 
load the sample DNA and kept for 30 minutes for gel to be solidified. Then, it was 
replaced into the electrophoresis tank and tank filled with 1x TAE buffer. 
The DNA samples were mixed with loading dye and then loaded into the agarose gel. 
MassRuler™ DNA Ladder, Mix (80bp-10kb) was used for size control. 
Electrophoretic separation was performed at a constant current for 40 minutes at 90 
mV. 
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Finally, agarose gel was stained with ethidium bromide and then visualized under 
UV illumuminator that emits UV light at 302 nm. Agarose gel was photographed 
with a camera connected to a computer and images were stored with UVIPhotoMW 
Version 99.05 for Windows 95 & 98, UVItec Ltd. The size of the DNA was 
determined by comparing with the MassRuler DNA marker. 
2.2.1.4 DNA fragment isolation from agarose 
In the presence of a chaotropic salt, DNA specifically binds to the silica or glass 
surfaces since chaotropic salt disrupts the water molecules’ intact structure, and it 
also disrupts its interaction with DNA. As the binding to silica/glass surfaces is 
specific for DNA, impurities are washed away during the process, and the pure DNA 
is eluted with water. 
“QIAquick Gel Extraction Kit” was used to elute DNA fragments from agarose gels. 
The QIAquick system utilizes the spin-column technology and a silica-gel membrane 
with selective binding properties. Elution was performed by following instructions of 
the manufacturer. 
The DNA fragment was excised from the agarose gel under UV illuminator using a 
scalpel. The gel slice was weighed in a colorless tube. Solubilization buffer that is 3 
volumes of the weight of agarose was added for 1 volume of gel (100 mg ~ 100 μl). 
It was incubated for 10 minutes at 50°C. After the gel slice was completely 
dissolved, the color of the mixture was checked to be yellow. The sample was mixed 
with one volume of isopropanol. A QIAquick spin column was replaced in a 2 ml 
collection tube. The sample was applied to the QIAquick column to bind DNA, and 
subjected to 1 minute centrifugation.  Flow-through was discarded and QIAquick 
column was placed back in the same collection tube. 0.5 ml of solubilization buffer 
was added to QIAquick column and 1 minute centrifugation was applied. 0.75 ml of 
washing buffer was added to QIAquick column and 1 minute centrifugation was 
applied. The flow-through was discarded and the QIAquick column was centrifuged 
for an additional 1 minute at 10,000 x g (~13,000 rpm). QIAquick column was 
placed into a clean 1.5 ml microcentrifuge tube. 50 μl of H2O was added to the 
QIAquick membrane to elute DNA and the column was centrifuged at maximum 
speed for 1 minute. 
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2.2.1.5 Restriction reactions for SpeedyRINGO and pIRES 
Restriction enzymes are known to be vehicles of bacterial mechanism to survive 
against viral attacks. A restriction enzyme only recognizes and cuts specific 
nucleotide sequences, named “recognition sequence”. A restriction enzyme binds to 
its recognition sequence and cuts each of the 2 sugar-phosphate backbones of the 
DNA fragment. Most of the enzymes make staggered incisions, generating “sticky 
ends”, while a small portion of the enzymes make immediately opposite incisions on 
the DNA strand, generating “blunt ends”. 
By PCR reaction, SpeedyRINGO was obtained with Nhe I and EcoR I restriction 
sites on its 5’ and 3’ ends, respectively. After that, both SpeedyRINGO gene and 
pIRES vector were cut using Nhe I and EcoR I enzymes. 
Restriction reactions for pIRES vector and SpeedyRINGO were performed as in the 
Table 2.7 and Table 2.8, respectively: 
Table 2.7 : Restriction reaction for pIRES. 
Ingredient Final Concentration 
pIRES (0,5 µg/ µl) 1 µg 
Nhe I (10 U/ µl) 10 U 
EcoR I (10 U/ µl) 10 U 
10x Tango Buffer 2x 
Water up to 30 µl 
Table 2.8 : Restriction reaction for SpeedyRINGO. 
Ingredient Final Concentration 
SpeedyRINGO (0,1 µg/ µl) 1 µg 
Nhe I (10 U/ µl) 10 U 
EcoR I (10 U/ µl) 10 U 
10x Tango Buffer 2x 
Water up to 30 µl 
Restriction reactions were incubated for 3 hours at 37 
0
C. Then they were loaded on 
1% agarose gel and purified from there with gel extraction method. 
2.2.1.6 SpeedyRINGO-pIRES ligation reaction  
Ligation process covalently binds linearized DNA fragments together. In other 
words, DNA ligation creates a phosphodiester bond between the 3' hydroxyl of one 
nucleotide and the 5' phosphate of another. T4 DNA ligase is used for ligation of  
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DNA fragments. Ligation mixture was prepared by adding compounds given in the 
Table 2.9 and ligation mixture was incubated at room temperature for overnight: 
Table 2.9 : Ligation reaction for SpeedyRINGO-pIRES. 
Ingredient Final Concentration 
pIRES (0,4 µg/µl) 0,4 µg 
SpeedyRINGO (0,03 µg/µl) 0,45 µg 
10x Ligase buffer 1x 
Ligase (100 U/ ml) 0,2 U 
PEG 8000 2,5 µl 
Water up to 25 µl 
2.2.1.7 Colony PCR 
In order to determine if a colony on a plate bears the desired DNA sequence, colony 
PCR technique is used. Universal or sequence specific primers can be used for 
colony PCR reaction. In this study, both M13 F/R Universal primers (Invitrogen) and 
SpeedyRINGO-sequence specific primers were used. A short procedure of colony 
PCR is as follows;  
First, cells were transformed and incubated overnight at 37°C. Then, 10 white 
colonies, which were expected to have the DNA of interest, were selected and 
picked. Each of them was resuspended in 50 μl sterile water. Then resuspended cells 
were heated at 100°C for 5 minutes to disrupt the bacterial cells. A PCR master mix 
was prepared by adding the compounds in the Table 2.10: 
Table 2.10 : Colony PCR reaction mixture. 
Ingredient Final Concentration 
10x PCR buffer 1x 
MgCl2 (25mM) 3 mM 
10x GC Melt 1x 
dNTP(10mM each) 0,2 mM each 
T7 forward primer 1 mM 
T3 reverse primer 1 mM 
Taq DNA Polymerase 1,25u/50 µl 
ddH2O up to 240 µl 
The master mix was equally distributed into PCR tubes. Following this, 1 μl of 
resuspended cells from each colony was added to PCR mixture. Colony PCR 
reaction was performed with the program in Table 2.11 using a thermal cycler and 
PCR reaction result was visualized on %1 agarose gel: 
28 
 
Table 2.11 : Colony PCR reaction conditions. 
Cycles Temperature, ºC Time 
 
1 
 
94 
 
 
2 minutes 
 
 
3 
94 
67 
68 
30 seconds 
30 seconds 
 3 minutes 
 
 
3 
 
94 
66 
68 
 
30 seconds 
30 seconds 
 3 minutes 
 
 
6 
 
94 
65 
68 
 
30 seconds 
30 seconds 
3.5 minutes 
 
 
6 
 
94 
64 
68 
 
30 seconds 
30 seconds  
 4 minutes 
 
 
6 
 
94 
64 
68 
 
30 seconds 
30 seconds 
4.5 minutes 
 
 
5 
 
94 
64 
68 
 
30 seconds 
30 seconds 
 5 minutes 
 
 
5 
 
94 
64 
68 
 
30 seconds 
30 seconds 
5.5 minutes 
 
 
6 
 
94 
64 
68 
 
30 seconds 
30 seconds 
 6 minutes 
 
Final extention 
 
68 
 
10 minutes 
 
Final hold 
 
4 
 
------------ 
2.2.2 Hippocampal neuron culturing 
Hippocampi of PN0 Spraque-Dawley rats were dissected using stereo microscopy 
and then were collected in dissection medium comprised of 1% 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES, 15630-080; Invitrogen), 1% 
Penicillin/Streptomycin (P4333; Sigma-Aldrich, St Louis, MO, USA) and 10% 
Hank's Balanced Salt Solution (14185; Invitrogen, Carlsbad, CA,USA). The 
disruption of the hippocampi was performed both mechanically and enzymatically, 
for which trypsin 2.5 % (15090-046, Invitrogen) and DNase (AMPD1, Sigma-
Aldrich) were added. Following this, the hippocampi were incubated at 37°C for a 30 
minute period.  
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Pieces of hippocampi were then triturated 6-7 times using fire polished Pasteur 
pipettes in a plating medium of Neurobasal Medium (12349-015; Invitrogen), 2% 
B27 Supplement (17504-044; Invitrogen), 45% D-Glucose (G8769, Sigma-Aldrich), 
0.5% L-Glutamine (03-020-1, Biological Industries) and 10% fetal bovine serum 
(FBS) (04-007-1, Biological Industries) with the purpose of obtaining single cell 
suspension. Following this, the suspension was centrifuged at 130 x g for a 5 minute 
period at room temperature. The number of cells in the suspension was determined 
using a hemacytometer. The ratio of glial cells to neurons was measured and found 
out to be 10% in all conditions. To do this, 4',6-diamidino-2-phenylindole (DAPI) 
was used to label the nuclei of all the cells in the culture for the purpose of counting 
all the cells (neuronal, glial) in the culture and neuron-specific beta-III-tubulin 
antibody was used to label the neurons so that only neurons would be counted in the 
culture and obtain a glial-cell ratio. 1x 10
6 
neurons were plated onto each 34 mm 
culture dishes coated with poly-L-lysine for Quantitative Polymerase Chain Reaction 
(qRT-PCR), 3x10
6
 neurons were plated onto 25 cm
2
 flasks for Western blotting and 
3 x 10
4 
neurons were plated onto each 18 mm cover slip coated with poly-L-Lysine 
(P8920, Sigma-Aldrich) for immunofluorescence analysis. A plating medium 
without FBS at 5% CO2 and 37°C was used to house all cultured cells. 
2.2.3 Design of the experiment 
The experimental design was based on three conditions due to the fact that the 
primary goal of the study was to find out the survival effect of SpeedyRINGO on 
specifically calpain-based apoptosis in neurons. One such condition was to induce 
calpain without expressing SpeedyRINGO in neurons in order to determine if over-
activity of calpain would indeed result in a change in related protein levels, such as 
caspase-3, p53 and CDK5. The second condition was transfection and expression of 
SpeedyRINGO followed by calpain induction for the purpose of observing 
preventative effect of SpeedyRINGO on calpain-based caspase-3 activation in 
hippocampal neurons. The last was the control condition, which served to compare 
the results of treated cells to non-treated cells. 
Homo sapiens Speedy A isoform 1 of SpeedyRINGO 
(http://www.ncbi.nlm.nih.gov/nuccore/AY820303.1, Last updated February 21, 
2007.) was a kind gift from Prof. Daniel J. Donoghue (Department of Chemistry and 
30 
 
Biochemistry, University of California San Diego) as myc-tagged Speedy A - pCS3 
construct. Before starting the experiment, subcloning of Speedy A into pIRES 
expression vector (631605, Clontech Laboratories) was carried out.  
After hippocampal cultures were prepared, with an Amaxa Nucleofector
®
 Device 
(AAD-1001, Lonza),  Speedy A - pIRES construct (7 µg) was electroporatically 
transfected into neurons for the "SpeedyRINGO expressing calpain induced neurons" 
experimental group and was incubated for a 30-hour period. After this, calpain was 
induced and an additional 18 hours of incubation was carried in order to complete a 
total 48 hours of SpeedyRINGO expression, as a 48 hour- incubation period was the 
minimum requirement for the expression of an appropriate amount of SpeedyRINGO 
within low-copy number pIRES expression vector in neurons. Cultures were kept in 
a 5% CO2 environment at 37°C. To induce the calpain activation, a 3 µM A23187 
Calcium
 
ionophore (C7522, Sigma-Aldrich) solution was prepared using 0.1% 
Dimethyl sulfoxide (DMSO) and this solution was added to the culture and incubated 
at 37°C for 15 minutes. Then, a calcium medium (3mM KCl, 0,25 mM CaCl2, 10 
mM Hepes, 15 mM Sucrose, 139 mM NaCl, 5 mM Glucose) was replaced by the 
ionophore-containing medium and cultures were maintained at room temperature for 
10 minutes. 
In the other experimental group (calpain activation without SpeedyRINGO 
expression) hippocampi were prepared and then electroporatically transfected with 
empty pIRES vector (1 µg) in order normalized against possible procedural effects 
and allowed to incubate for 30 hours to attain identical conditions to the experimental 
group with SpeedyRINGO expression followed by calpain induction. Following this, 
calpain was induced using A23187 Calcium
 
ionophore and Calcium
 
medium in the 
last 18 hours of the total 48 hours of expression of empty pIRES vector. 
In the control group, the empty pIRES vector (1 µg) was used to transfect the 
neurons and the neurons were then incubated for a 30-hour period to mimic 
SpeedyRINGO-pIRES expression. After this, 0.1% DMSO was applied to these 
control neurons, since the calpain was induced using Calcium
 
ionophore in 0.1% 
DMSO. Then, control neurons were incubated at 37°C for 18 hours in 5% CO2 . 
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2.2.4 Measuring calpain activity 
In all groups, the activity of calpain was measured with Fluorogenic Calpain Activity 
Assay Kit (QIA120, Calbiochem) using manufacturer instructions. To summarize, 
proteins from ionophore-treated and diluent-treated control cells were lysed using 
CytoBuster
TM
 Protein Extraction Reagent (71009, Calbiochem). A BCA protein 
assay kit (23227, Pierce) was used to measure protein concentrations and 20 µg of 
total protein was used in calpain activity assay for all groups. The reported data are 
in relative fluorescence units (RFU), which are defined by manufacturer instructions. 
The value of the blank was subtracted from the values of fluorescence obtained from 
all samples to normalize the results. Then, duplicate readings were used to determine 
mean fluorescent value. 
2.2.5 Analysis of quantitative real time polymerase chain reaction  
Probes and primers used in this study were all purchased from Roche Universal 
Probe Library and are listed in Table 2.12. To use as references for qRT-PCR 
studies, Rat ACTB Gene Assay (Beta-actin) (05046203001, Roche Universal 
ProbeLibrary) and Rat GAPD Gene Assay (Glyceraldehyde 3-phosphate 
dehydrogenase / GAPDH) (05046220001, Roche Universal ProbeLibrary) were 
purchased.  
Table 2.12 : Primer and probe sequences for qRT-PCR. 
Gene name Accession 
number 
Primer sequence Probe number 
Cyclin D1 NM_171992.4 gcacaacgcactttctttcc 
tccagaagggcttcaatctg 
16 
p27 NM_031762.3 agacagtccggctgggtta 
ttctgttctgttggcccttt 
130 
CDK5 NM_080885.1            ctgcgatgcagaaatacgag 
tggccttgaacacagttcc 
60 
Cyclin A NM_001011949.1 gagagggaaattgcagcttg 
gggcgggtatatctcttcgt 
2 
Cyclin B NM_171991.2 tgtgaaagatatctatgcttacctcag 
cccagtaggtattttggtctaactg 
65 
 
Cyclin E NM_001100821.1 ctgagagatgagcactttctgc 
tggagcttatagacttcacacacc 
108 
CDK4 NM_053593.2 gtcagtggtgccggagat 
ggattaaaggtcagcatttcca 
50 
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For preparing stock solution for all the primers, they were diluted as a concentration 
of 200 µM. After that, 2 µM working solution was prepared from the stock solution 
for each of the primers.  
All the probes were in 10 µM concentration. Each of them was 1:10 diluted to 
prepare 1 µM working solution. 
RNA was isolated by High Pure RNA Isolation Kit (11828665001, Roche). RNA 
concentration measurements were performed by Qubit
®
 Fluorometer (Q32857, 
Invitrogen) using Quant-iT™ RNA, BR Assay Kit (Q10210, Invitrogen). cDNA 
synthesis was done with Fermentas RevertAid™ H Minus First Strand cDNA 
Synthesis Kit (K1631, Fermentas, Glen Burnie, MD, USA).  
qRT-PCR reactions were performed using a Light Cycler
®
 480 Probes Master qRT-
PCR Kit (04902343001, Roche) in a Roche Light Cycler 480 following the program: 
1 cycle of 10 minutes initial denaturation at 95°C, followed by 45 cycles of, 10 
seconds of denaturation at 95°C, 30 seconds of amplification at 60°C, and 1 second 
of extension at 72°C.  
All experiment groups were analyzed by the described qRT-PCR program 3 times 
with duplicates in order to exactly determine the changes in their mRNA level 
profiles. 
2.2.5.1 Determining efficiency and error rate 
In this study, it was aimed to use ∆∆Ct method to analyze our RT-PCR results 
(Schmittgen, 2008). First of all, as a requirement of this method, error rate and 
efficiency values for each gene were determined. According to the literature, in order 
to be able to use this method, efficiency rate for each gene should be between 1.8-2.2 
and error rate should be below 0.2.  
For this reason, primary hippocampal neuron culture was prepared by using newborn 
rats. Then RNA isolation was performed and by using obtained RNA, cDNA  was 
synthesized with the help of Reverse Transcriptase. After that, 4 different dilutions 
(undiluted, 1.10, 1:100, 1:1000) of cDNA templates were prepared in order to use in 
RT-PCR reactions and by using Roche TaqMan  RT-PCR kit and  Roche Light 
Cycler 2.0  four separate reaction was performed for each gene. Results were 
analyzed by using  Roche Light Cycler 2.0  software. 
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2.2.6 Analysis of immunofluorescence  
Phosphate Buffered Saline (PBS, P4417, Sigma-Aldrich) was used to wash all the 
neurons, which were then fixed using 100% methanol (494437, Sigma-Aldrich) for 
10 minutes at -20°C. Following this, neurons were washed with PBS for 3 times and 
incubated with a blocking solution made of  10% goat (04-009-1, Biological 
Industries) or donkey serum (D9663, Sigma-Aldrich), 10 mg/ml Bovine Serum 
Albumin (A9418, Sigma-Aldrich) in PBS at room temperature for 1 hour. Then, the 
cells used in the experiment were incubated overnight with primary antibodies 
against CyclinD1 (rabbit polyclonal IgG, sc-717, Santa Cruz Biotechnology), CDK5 
(mouse monoclonal IgG, sc-6247, Santa Cruz Biotechnology), Beta-III- Tubulin 
(mouse monoclonal IgG, G7121, Promega) in a dilution of 1:1000, and with primary 
antibody against SpeedyRINGO (rabbit polyclonal IgG, PA1-16959, Affinity 
Bioreagents) in a dilution of 1:500. Cells were again washed in PBS 3 times and 
incubated in blocking solution at room temperature for 1 hour. Following the 
blocking step, cell incubation was carried out at a dilution of 1:1000 of secondary 
antibodies, Alexa Fluor® 488 goat anti-mouse IgG (A11029, Invitrogen), Alexa 
Fluor® 647 goat anti-rabbit IgG (A21245, Invitrogen), Alexa Fluor® 647 donkey 
anti-rabbit (A31573, Invitrogen) at 37°C for 1 hour in dark. Finally, cells were 
washed in PBS 3 times and were analyzed at 63x oil objective under Leica TCP SP2 
SE Confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany) and the 
pixels were analyzed integratively to calculate the expressional values of the studied 
proteins. 
2.2.7 Western blotting 
Mammalian Cell Extraction Kit (K269-500, BioVision, Mountain View, CA, USA) 
was used to extract total protein from 3x10
6 
neurons for each experimental group  
using a cocktail of protease inhibitors provided with the extraction kit. The 
measurements for the protein concentration were done with the BCA protein assay 
kit (Pierce). Equal amounts (10 μg protein/lane)  of samples  were loaded on and 
separated by SDS-PAGE (12,5% or 10% sodium dodecyl sulfate-polyacrylamide 
electrophoresis based on the molecular weight of the proteins) and then transferred to 
nitrocellulose membrane ( sc-3724, Santa Cruz Biotechnology) by a semi-dry 
blotting system (170-3940, BioRad). 5% BSA/Tris Buffered Saline-Tween (TTBS) 
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was used to block the membranes at room temperature for 2 hours. The membranes 
were stained overnight with the primary antibody at 4°C and with the secondary 
antibody at room temperature for 1 hour. The primary antibodies used at 1:500 
dilutions were the following; mouse monoclonal anti-actin (sc-8432, Santa Cruz 
Biotechnology), mouse monoclonal anti-CDK5 (sc-6247, Santa Cruz 
Biotechnology), mouse monoclonal anti- p27
kip
 (sc-1641, Santa Cruz 
Biotechnology), mouse monoclonal anti-p53 (2524, Cell Signalling Tech.), mouse 
monoclonal anti-CDK2 (AHZ0142, Biosource), and rabbit monoclonal anti-caspase-
3 (9665S, Cell Signaling Tech.) in 5% BSA/TTBS. After being incubated with 
primary antibodies, TTBS buffer was used to wash the membranes 6 times for 5 
minutes each at room temperature. After this, they were incubated with solutions of 
differing anti-HRP (W4011, W4021, V8051, Promega) secondary antibodies at 
1:5000 dilution at room temperature for 1 hour. Blots were analyzed with ECL Plus 
Western Blotting Detection Reagents (RPN2132, GE Healthcare, Munich, 
Germany). Blots were scanned and the measurements of specific band densities were 
quantified and normalized based on actin as loading control.  
2.2.8 Analysis of apoptosis by DAPI staining and TUNEL assay 
DAPI staining was used to analyze nuclear condensation as an indicator of apoptosis. 
Cells were washed in PBS 3 times, then permeabilized, and finally incubated with l 
µg/ml of DAPI in dark for 5 minutes for nuclear staining. Cells were then visualized 
under confocal microscopy at 63x magnification. 
TUNEL Assay was also performed to evaluate apoptosis for both experimental 
conditions and for a set of untreated neurons as a negative control with APO-BrdU™ 
TUNEL Assay Kit (A35125, Invitrogen, Molecular Probes) following the 
manufacturer’s instructions using confocal microscopy imaging. Imaging analysis 
was performed at 63x magnification with 100 cells/slide. The results were 
represented as % of TUNEL positive neurons. 
2.2.9  Analysis of lactate dehydrogenase (LDH) cytotoxicity  
Measurement of LDH release for all conditions was made with Roche Cytotoxicity 
Detection Kit (11644793001, Roche), in accordance with the instructions of the 
manufacturer. First, primary neurons were plated as 5.000 cells/well onto 96 well-
plates. Coupled with experimental conditions, low control was used to gather 
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information about activity of LDH released from the control cells, and a high control 
was used to gather information about maximum possible LDH release in the cells 
and finally a background control was used for information about the assay medium’s 
LDH activity. These measurements were done with an ELISA reader at 492 nm. In 
order to calculate the cytotoxicity, the triplicates’ average absorbance was calculated 
and each of these absorbance was subtracted from the background control 
absorbance.  
2.2.10 Statistical analysis 
Statistical Package for the Social Sciences (SPSS) Statistical Analysis Program was 
used to analyze the results using "paired-2 tailed student's t test". A value of P below 
0.05 was deemed significant and a value below 0.001 was deemed very significant 
across all results. Error bars in the graphs were generated using ± s.e.m. values for 
qRT-PCR and ± s.d. values for immunofluorescence, Western blotting and calpain 
activity analysis.  
2.2.11 Integrative pixel analysis 
Immunofluorescence results were pixel-analyzed using ImageJ Software. For each of 
the experimental conditions, in excess of 100 cells were analyzed. When images 
were taken with the same brightness-contrast, exposure and gain settings, 
background subtraction was done to get total fluorescence and normalized integrated 
densities. For Western blot images, Photoshop CS4 Software was utilized for relative 
intensity analysis of the protein bands. First, for untreated cells the obtained 
expressional value was set to ‘1’, and then based on this, the relative expression 
changes of the two other experimental conditions were calculated. 
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3.  RESULTS 
3.1 Subcloning of SpeedyRINGO into pIRES Expression Vector 
3.1.1 PCR cloning of SpeedyRINGO 
In order to subclone SpeedyRINGO (Figure 3.1) from pCS3 vector into pIRES, first, 
SpeedyRINGO was cloned out from pCS3 by PCR using primers that were 
specifically designed for SpeedyRINGO. All the primers were designed by adding 
restriction sites on their 5’ ends. These restriction sites were then used for pIRES- 
SpeedyRINGO ligation studies.  
 
Figure 3.1 : Homo sapiens SpeedyRINGO DNA sequence. 
Result of PCR reaction was then visualized with 1% agarose gel electrophoresis and 
it was observed that 861 bp SpeedyRINGO was successfully cloned out from pCS3 
vector (Figure 3.2).  
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Figure 3.2 : Electrophoresis result of SpeedyRINGO PCR reaction showing 
successful cloning of SpeedyRINGO out from pCS3 vector. 1% 
agarose gel was used for electrophoresis and Fermentas Mass Ruler, 
Mix DNA Ladder was used for size determination of SpeedyRINGO. 
After that, all PCR products are loaded on agarose gel and then purified from the gel 
by gel extraction method (Figure 3.3). 
 
Figure 3.3 : Gel purification result of SpeedyRINGO DNA showing successful 
isolation of SpeedyRINGO from agarose gel. DNA fragment from 
agarose gel using “ QIAquick Gel Extraction Kit” and Fermentas 
Mass Ruler, Mix DNA Ladder was used for size determination of 
SpeedyRINGO.  
3.1.2 Restriction reactions for SpeedyRINGO and pIRES 
By this PCR reaction, SpeedyRINGO was obtained with Nhe I and EcoR I restriction 
sites on its 5’ and 3’ ends, respectively. After that, both SpeedyRINGO gene and 
pIRES vector were cut using Nhe I and EcoR I enzymes. 
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Figure 3.4 : pIRES vector multiple cloning sites (MCS A and MCS B). 
As shown in the Figure 3.4, pIRES was cut and linearized by Nhe I and EcoR I 
enzymes, which had restriction sites in MCS A.  
As the same with pIRES restriction, SpeedyRINGO gene was cut with Nhe I and 
EcoR I enzymes by using restriction sites added to its 5’ and 3’ ends for further 
ligation study.  
Restriction reactions were incubated for 3 hours at 37 
0
C. Then they were loaded on 
1% agarose gel and purified from there with gel extraction method (Figure 3.5). 
 
Figure 3.5 : Electrophoresis result of restriction reactions. pIRES and SpeedyRINGO 
were both successfully cut by Nhe I and EcoR I enzymes. Restriction 
fractions were isolated form agarose gel using “QIAquick Gel 
Extraction Kit” and Fermentas Mass Ruler, Mix DNA Ladder was 
used for size determination of pIRES and SpeedyRINGO. 
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3.1.3 SpeedyRINGO-pIRES ligation reaction 
After restriction reactions were completed, ligation reaction was performed to insert 
SpeedyRINGO into pIRES vector. 
Ligation reaction was incubated overnight at room temperature. After that, ligation 
mixture was transformed into DH5α strain of E.coli. Since pIRES is ampicillin 
resistant, in order to obtain only transformed cells, cells were plated into ampicillin 
containing LB-agar plates and incubated overnight at 37 
0
C. After transformation, 
several numbers of colonies were grown on the plate. 
3.1.4 Colony PCR reaction 
In order to confirm that these colonies contained SpeedyRINGO-pIRES construct, 
colony PCR was performed. For this reason, colonies were picked up from the plate 
and each of them was put into water containing eppendorf tubes. Then, all the tubes 
were incubated at 100 
0
C for 10 minutes in order to lyse the cells. With this method, 
DNA content of the cells were obtained and then used as template for colony PCR 
reaction. After colony PCR, reaction results were visualized on 1% agarose gel 
electrophoresis and it was observed that all the colonies had the SpeedyRINGO-
pIRES construct (Figure 3.6). 
 
Figure 3.6 : Colony PCR results showing successful ligation and cloning of pIRES-
SpeedyRINGO construct. Escherichia coli (E.coli) DH5α cells were 
transformed with pIRES-SpeedyRINGO and 12 separate colonies 
picked up to detect whether or not colonies had pIRES-SpeedyRINGO 
sequence. Fermentas Mass Ruler, Mix DNA Ladder was used for size 
determination of pIRES-SpeedyRINGO construct. 
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3.2 Calpain Activity Measurement 
Calpain activity measurement was carried out to understand whether induction of 
intrinsic calpain by calcium ionophore was successful and sufficient and also to 
ensure that the observed effects in the experiments would specific to calpain over-
activity. Measurements showed a significant %10 increase (p= 0.02) in the activity 
of calpain in calcium ionophore-treated neurons compared to control neurons (Figure 
3.7).  
 
Figure 3.7 : Results of calpain activity measurement in ionophore-treated and in     
control neurons. Data are given as relative fluorescent units 
(RFU).Error bars represent mean values ± SD. n=3, * p<0,05. 
3.3 Expression of Transfected SpeedyRINGO in Hippocampal Neurons 
SpeedyRINGO was transfected to hippocampal neurons in order to understand 
whether SpeedyRINGO would successfully expressed in neurons. Results of 
immunofluorescence analysis indicated a 3.83 fold significant (p = 0.0007) increase 
in the expression level of SpeedyRINGO in transfected neurons showing the 
successful transfection and expression of SpeedyRINGO (Figure 3.8). Western 
blotting was also performed to confirm the results of immunofluorescence analysis 
and results showed that there was a 4.6 fold increase in SpeedyRINGO-transfected 
hippocampal neurons (Figure 3.8).  
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Figure 3.8 : Successful expression of SpeedyRINGO in transfected neurons.  a: beta-    
III-Tubulin and SpeedyRINGO expression in control (upper panel), 
SpeedyRINGO expressing ionophore-treated (middle panel) and only 
ionophore-treated (lower panel) neurons. Size bar: 49.62 µm b: 
Relative fluorescent intensities according to the experimental/control 
ratio of SpeedyRINGO expression. Results were represented as fold 
change. Bar represents mean values ± SD.   n=100, ** p< 0.001 c: 
Western blotting membrane probed with SpeedyRINGO antibody and 
actin antibody. d: Graph indicating quantitative analysis of signals in 
blots. Results were represented as fold change. Bar represents mean 
values ± SD. 
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3.4 Efficiency and Error Rate Values of GAPDH, ACTB, CDK5, Cyclin D1 and 
p27 Genes for qRT-PCR Analysis 
Efficiency and error rates were analyzed for each gene of interest. In order to use 
ΔΔCT method to analyze qRT-PCR results, efficiency rate for each gene should be 
between 1.8-2.2 and error rate should be below 0.2. Efficiency and error rates of each 
gene were in expected ranges and results were given in the Table 3.1: 
Table 3.1 : Efficiency and error rate values. 
Gene Efficiency Error Rate 
GAPDH 1.968 0.00875 
ACTB 1.899 0.0547 
CDK5 1.859 0.06 
Cyclin D1 1.918 0.009 
p27 1.889 0.00218 
Cylin A 1.973 0.0154 
Cyclin B 1.810 0.0141 
Cyclin E 1.859 0.009 
CDK4 1.934 0.00980 
3.5 Changes in Different Cell Cycle Markers’ mRNA Levels in the Presence / 
Absence of SpeedyRINGO in Calpain-Induced Hippocampal Neurons 
Since SpeedyRINGO is a meiotic / mitotic cell specific cell cycle regulator, all of the 
existing studies about SpeedyRINGO were performed in mitotic or meiotic cells. For 
this reason, it was first aimed to identify if SpeedyRINGO would be effective on a 
chaotic cell cycle reactivation attempt in calpain-induced post-mitotic neurons. For 
this purpose, different cell cycle markers were first analyzed in mRNA level in the 
absence or presence of SpeedyRINGO in calpain-induced neurons to see a possible 
upregulation of these markers in the presence of SpeedyRINGO, which would 
indicate a positive regulatory function for SpeedyRINGO on cell cycle reactivation 
attempt in neurons. mRNA analysis results showed that calpain over-activity resulted 
in chaotic up- and down-regulation of mRNA levels of different cell cycle markers 
(Cylin A, Cyclin B, Cyclin E, CDK4). SpeedyRINGO was shown to prevent this 
chaotic up- and down-regulation and kept mRNA levels similar to that of control 
neurons, as it was shown that there was no upregulation of cell cycle markers (Figure 
3.9).  
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Figure 3.9 : Changes in mRNA levels of Cyclin A, Cyclin B, Cyclin E and CDK4  in 
ionophore- treated and in SpeedyRINGO expressing ionophore-treated 
neurons. Data represent CT value of treated cell / CT value of 
untreated cells. Bar represents mean values ± SEM. n=3, * p<0.05. 
3.6 Changes in CDK5 and Cyclin D1 mRNA and Protein Levels After Calpain 
Induction 
Calpain over-activation forces neurons to exit from G0 and undergo apoptosis 
through CDK5 as the key factor, instead of CyclinD1, which is contrary to the 
conventional idea that CyclinD1 is required for G0 exit. Pathologic activation of 
calpain has also been shown to  lead neurons to undergo apoptosis indirectly, through 
CDK5 by increasing p53 and caspase-3 activation. Therefore, mRNA and protein 
level changes of CDK5 and CyclinD1 were determined. Results of Q-PCR indicated 
a 1.27 fold significant increase (p = 0,03) in mRNA level of CDK5 in calpain-
induced hippocampal neurons, while mRNA level of CyclinD1 significantly 
decreased (p = 0,04) (Figure 3.9). However, in SpeedyRINGO expressing calpain-
induced neurons, both CDK5 and CyclinD1 mRNA levels were decreased 
significantly (p= 0,01 and p= 0,04, respectively) (Figure 3.10).  
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Figure 3.10 : Changes in mRNA levels of CDK5 and Cyclin D1 in ionophore- 
treated and in SpeedyRINGO expressing ionophore-treated neurons. 
Data represent CT value of treated cell / CT value of untreated cells. 
Bar represents mean values ± SEM. n=3, * p<0.05. 
Besides changes in mRNA level, protein level changes were also determined with 
immunofluorescence. Immunofluorescence results indicated no detectable expression 
of CyclinD1 in either calpain-induced or control neurons (Figure 3.11). However, in 
calpain-induced neurons, there was a significant 1.64 fold increase in CDK5 
expression (Figure 3.12) which is in accordance with the change in mRNA level.  
 
Figure 3.11 : Changes in Cyclin D1 expression in ionophore-treated, SpeedyRINGO 
expressing ionophore-treated  and in control neurons. 1A: Cyclin D1 
(red) and beta tubulin (green) expression in neurons. 1B: Cyclin D1 
(red*) and beta tubulin (green) expression in control neurons. 2A: 
Cyclin D1(red) and beta tubulin (green) expression in SpeedyRINGO 
expressing ionophore-treated neurons. 2B: Cyclin D1 (red*) and beta 
tubulin (green) expression in control neurons. *Cyclin D1 was 
fluorescently labeled in red, however due to absence in neurons, it 
could not be detected. 
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Figure 3.12 : Changes in CDK5 protein level in three experimental conditions. a: 
beta-III-Tubulin and CDK5 expression in control (upper panel), 
SpeedyRINGO expressing ionophore-treated (middle panel) and only 
ionophore-treated (lower panel) neurons. Size bar: 49.62 µm b: 
Relative fluorescent intensities according to the experimental/control 
ratio of SpeedyRINGO expression. Results were represented as fold 
changes. Bar represents mean values ± SD.  n=100, ** p< 0.001. 
In order to support the results of immunofluorescence, western blotting was also 
carried out. Results showed a significant, 1.31 fold increase in CDK5 protein level in 
ionophore-treated neurons compared to control (Figure 3.13) which was also in 
accordance with the changes in CDK5 mRNA level. Moreover, in SpeedyRINGO 
expressing calpain over-activated neurons, CDK5 protein level was almost same with 
the control, supporting CDK5 mRNA results, CDK5 was also decreased in protein 
expression (Figure 3.13).  
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Figure 3.13 : Result of western blotting for CDK5. a: Changes in CDK5 protein 
level in ionophore-treated, in SpeedyRINGO expressing ionophore-
treated and in control hippocampal neurons. b: Graph indicating 
quantitative analysis of signals in blots. Results were represented as 
fold changes. Bar represents mean values ± SD. 
3.7 Upregulation of p27kip mRNA and Protein Levels After Only Calpain 
Induction 
p27
kip
 was also analyzed for the reason that p27
kip
 is a general inhibitor of the 
different phases of cell cycle regulators and calpain over-activation has been shown 
to upregulate p27, which in turn results in apoptosis (Noguchi, 2003). Q-PCR results 
of calpain activation experiments indicated that mRNA level of common CDK 
inhibitor p27
kip
 was increased; but upon SpeedyRINGO expression, mRNA level of 
p27
kip
 was significantly reduced (p = 0,048) (Figure 3.14a). Besides that, western 
blotting analysis showed a 1.58 fold increase in protein expression of p27
kip
 after 
ionophore-treatment, while p27
kip
 expression was decreased after SpeedyRINGO 
expression followed by ionophore-treatment compared to control neurons (Figure 
3.14b). 
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Figure 3.14 : Results of mRNA and protein level changes of p27. a: mRNA level 
changes in ionophore-treated, SpeedyRINGO expressing ionophore-
treated and in control neurons. b: Changes in p27 protein level  in 
ionophore-treated, in SpeedyRINGO expressing ionophore-treated and 
in control hippocampal neurons. c: Graph indicating quantitative 
analysis of signals in blots. Results were represented as fold changes. 
Bar represents mean values ± SD. 
3.8 Over-expression of CDK2 Protein After SpeedyRINGO Expression  
As CDK2 is the specific partner of SpeedyRINGO and it cannot properly function in 
the absence of CDK2, CDK2 protein level was also analyzed in expectation of an 
increase in CDK2 level in SpeedyRINGO-transfected neurons. For this purpose, 
western blotting was performed and results indicated that there was a 1.52 fold 
increase in protein level of CDK2 in SpeedyRINGO expressing neurons, whereas 
there was not an obvious change in ionophore-treated neurons (Figure 3.15).  
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Figure 3.15 : Results of western blotting for CDK2. a: Change in CDK2 protein 
level in SpeedyRINGO expressing neurons. b: Graph indicating 
quantitative analysis of signals in Panel A. Results were represented 
as fold changes. Bar represents mean values ± SD.   
3.9 Up-regulation of p53 Protein After Calpain Over-activation in the Absence 
or Presence of SpeedyRINGO 
Since p53 expression is a necessity for SpeedyRINGO to prevent calpain-mediated 
apoptosis by inhibiting caspase-3 activation, it was crucial to determine the p53 
protein level in ionophore-treated, SpeedyRINGO expressing ionophore-treated and 
in control neurons. For this reason, western blotting was performed and a 1.24 fold 
increase in p53 protein level in ionophore-treated neurons, and a 1.33 fold increase in 
SpeedyRINGO expressing ionophore-treated neurons were observed according to 
western blotting results (Figure 3.16).  
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Figure 3.16 : Results of western blotting for p53. a: Change in p53 protein level in   
SpeedyRINGO expressing neurons. b: Graph indicating quantitative 
analysis of signals in Panel A. Results were represented as fold 
change. Bar represents mean values ± SD. 
3.10 Prevention of Calpain-directed Caspase-3 Activation by SpeedyRINGO  
One of the major points in this study was to determine whether SpeedyRINGO had 
protective effects against caspase-3 activation caused by calpain over-activity in 
neurons. Thus, western blotting was carried out for all experimental groups to show 
if there was an increase in active caspase-3 levels in calpain-overactivated neurons 
and also to show if there was an inhibition of this caspase-3 activation by 
SpeedyRINGO. Western blotting results showed a 1.37 fold increase in active 
caspase-3 level as a result of calpain activation in ionophore-treated neurons 
compared to control neurons, whereas level of active caspase-3 was decreased in 
SpeedyRINGO expressing ionophore-treated neurons compared to control indicating 
inhibition of caspase-3 activation by SpeedyRINGO (Figure 3.17). 
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Figure 3.17 : Results of western blotting for active caspase-3. a: Change in active 
caspase-3 protein level in SpeedyRINGO expressing neurons. b: 
Graph indicating quantitative analysis of signals in Panel A. Results 
were represented as fold change. Bar represents mean values ± SD. 
3.11 Detection of Apoptosis by DAPI Staining in Ionophore-treated and 
SpeedyRINGO Expressing Ionophore-treated Neurons 
DAPI staining was performed to analyze DNA condensation in calpain over-
activated neurons as a hallmark of apoptosis and to determine whether 
SpeedyRINGO would inhibit the progression of apoptosis. Results of DAPI staining 
were analyzed with confocal microscopy and it was shown that there was a marked 
DNA condensation in the nuclei of ionophore-treated neurons, whereas 
SpeedyRINGO-expressing ionophore-treated neurons had intact and uniformly 
stained nuclei (Figure 3.18). It was also detected that there was an enlargement in the 
nuclei of apoptotic neurons as a result of initiation of DNA fragmentation (Figure 
3.18, lower left panel) which indicates early stages of apoptosis (Yang, 2007). 
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Figure 3.18 : Results of DAPI staining. DAPI staining (blue) in control (upper left 
panel), in calpain-induced (lower left panel), in SpeedyRINGO 
expressing ionophore-treated (upper right panel) neurons and 
SpeedyRINGO expression (red) in  SpeedyRINGO expressing 
ionophore-treated (lower right panel) neurons. Size bar: 47.62µm. 
3.12 Detection of Apoptosis by TUNEL Assay in Only Calpain-induced and 
SpeedyRINGO Expressing Calpain-induced Neurons 
In order to detect nuclear DNA-fragmentation as a hallmark of apoptosis which 
could be caused by calpain induction, and also to detect if SpeedyRINGO could 
prevent this progress, TUNEL assay was performed and results were analyzed by 
confocal microscopy imaging. TUNEL assay indicated that only calpain induction 
caused 65% apoptotic cells in the primary hippocampal neurons (Figure 3.19), while 
SpeedyRINGO-expressed calpain-induced neurons did not give any apoptotic signals 
with TUNEL analysis. 
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Figure 3.19 : TUNEL analysis of DNA damage in calpain-induced neurons. 1A: 
Transmission image of calpain-induced neurons. 1B: TUNEL-positive 
neurons (red) in calpain-induced neuron culture. 2A: Transmission 
image of SpeedyRINGO expressing calpain-induced neurons. 2B: 
TUNEL-positive neurons (red) in SpeedyRINGO expressing calpain-
induced neuron culture. 
3.13 Results of Cytotoxicity Analysis  
Cytotoxicity analysis was performed for all experimental conditions as a function of 
released LDH from neurons to be able to identify SpeedyRINGO’s recovery effort 
against calpain-based cytotoxicty in neurons. LDH cytotoxicity measurements 
indicated relatively more toxicity for calpain-induced neurons (29.53%) compared to 
SpeedyRINGO expressing calpain-induced neurons (10.91%). It means that 
SpeedyRINGO caused an approximately 3 fold decrease in the calpain cytotoxicity 
when expressed before inducing calpain in neurons (Figure 3.20). 
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Figure 3.20 : Results of LDH cytotoxicity analysis. Data are given as relative LDH 
activity (%) in ionophore-treated and in SpeedyRINGO expressing 
ionophore-treated neurons. Bar represents mean values ± SD.     
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4.  DISCUSSION 
Calpain over-activity has been shown to directly (through p53 induction) (Hamdane, 
2005; Alvira, 2008; Sedarous, 2003) or indirectly (by up-regulating CDK5 which 
would in turn re-activate cell cycle and also upregulate p53 expression) lead neurons 
into apoptosis. Thus, one of the main aims of this study was to regulate chaotic cell 
cycle re-activation attempt using SpeedyRINGO, a novel cell cycle regulator, to tip 
the balance in favor of division rather than apoptosis in degenerating neurons. 
Another major target of the study was to prevent the apoptotic effect of calpain in 
degenerating neurons utilizing anti-apoptotic function of  SpeedyRINGO in calpain-
induced neurons. 
For these purposes, first calpain was induced by calcium ionophore in neurons. In 
order to ensure that calpain induction was successful and also to ensure that the 
observed effects in the experiments were indeed calpain-specific, calpain activity 
was measured after induction by calcium ionophore. Measurement results indicated 
10% increase in calpain activity in calpain-induced neurons compared to control 
neurons. Since visualizing the gradual progression of calpain-mediated apoptotic and 
neurodegenerative pathway was crucial in this study, low concentration of calcium 
ionophore and a short incubation period (18 hours) were preferred not to cause 
sudden and rapid apoptotic death of neurons. Thus, a significant 10% increase in 
calpain activity was sufficient in this context. 
In addition, efficient transfection and expression of SpeedyRINGO in neurons was 
also analyzed and the results showed that a mitotic protein, SpeedyRINGO, could be 
effectively expressed in non-mitotic neurons. 
After ensuring the success of calpain induction and SpeedyRINGO expression in 
neurons, in order to identify regulatory effect of SpeedyRINGO on cell cycle re-
activation in neurons, mRNA levels of different cell cycle markers were first 
analyzed in the absence and presence of SpeedyRINGO in calpain-induced neurons 
to see a possible upregulation of these markers in the presence of SpeedyRINGO 
which would indicate a possible regulatory effect for SpeedyRINGO on  calpain-
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based cell cycle re-activation in neurons. Results showed that there was no 
upregulation of these markers indicating that SpeedyRINGO did not have an 
inducing effect on cell cycle markers but it may have a protective effect against 
calpain-mediated cell cycle re-activation in neurons by keeping cell cycle marker 
levels similar to that of control neurons.  
Cell cycle re-activation in calpain- induced neurodegeneration has been shown to be 
through CDK5 protein, rather than conventional Cyclin D1 protein. CDK5 is a non-
mitotic kinase that is normally found in neurons, having role in development and 
maturation (Dhariwala, 2008;Yip, 2007; Fu, 2006). However, CDK5 has been shown 
to be a contributing factor in some neurodegenerative diseases that accelerate 
apoptosis.   
 In calpain-induced neurons, it has been shown that pRb protein is a substrate for 
CDK5 and CDK5 phosphorylates and inactivates pRb so that cell cycle progresses 
through G1/S transition in degenerating neurons (Hamdane, 2005; Alvira, 2008). 
Thus, if CDK5 level abnormally increases, it would cause an increase in pRB 
phosphorylation and result in aberrant cell cycle activation in neurons. This aberrant 
cell cycle activation ends up with apoptosis instead of division.  
In addition to its role in calpain-mediated cell cycle re-activation in neurons, CDK5 
has also been shown to upregulate p53, since p53 has been shown to be one of the 
substrates of CDK5 so that it can modulate both activity and expression of p53. 
Thus, increased CDK5 level results in upregulation of p53 protein due to the 
upregulation of its transcriptional activity (Zhang, 2002) which would finally end up 
with apoptosis.  
Therefore, analyzing the changes in CDK5 mRNA and protein levels upon calpain 
activation was essential in revealing the initiation of the apoptotic process. In 
addition, it was crucial to determine a possible increase in CDK5 mRNA and protein 
levels, which could indicate a different function for it, such as re-activation of cell 
cycle.  
The analysis results showed that over-activation of calpain increased CDK5 mRNA 
level significantly, which was followed by a corresponding fold increase in CDK5 
protein level which may indicate re-activation of cell cycle and also initiation of 
apoptotic process in neurons.  
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While there were an increase in CDK5 mRNA and protein levels, there was a 
decrease in Cyclin D1 mRNA, and there was no detectable Cyclin D1 protein upon 
calpain activation. All these results were consistent with the findings that calpain-
mediated G0 exit is caused by CDK5 rather than CyclinD1. In addition, it is possible 
that Cyclin D1 may still be contributing to the G0 to G1 transitions of neurons. Yet, 
decreased levels of CyclinD1 in calpain-induced neurons may indicate that CDK5 
could bring neurons to further in G1 phase, rather than only G0 exit, as it is known 
that CyclinD1 levels must be high at the beginning of G1 phase for a cell to initiate 
DNA synthesis, but then must be down-regulated towards the end of G1 phase to 
allow for subsequent efficient DNA synthesis. This down-regulation is regulated 
only by the phase of the cell cycle and occurs during each cell cycle (Yang, 2006).  
Contrary to the results in the calpain-induced condition, after SpeedyRINGO 
expression followed by calpain induction, CDK5 upregulation was significantly 
inhibited in both mRNA and protein expression levels indicating efficient prevention 
of CDK5 upregulation by SpeedyRINGO. Inhibition of CDK5 upregulation in those 
neurons may also be the reason of SpeedyRINGO for preventing chaotic up- and 
down-regulation of cell cycle markers and keeping these markers at control levels in 
calpain-induced neurons (Figure 3.9). This finding is significant in that 
SpeedyRINGO, which regulates cell cycle progression only in some specific types of 
mitotic cells, is shown to be able to inhibit attempts of degenerative cell cycle re-
entry in post-mitotic neurons.  
In addition, based on the apoptotic role of calpain over-activation through CDK5, 
these results indicate that calpain over-activity indeed upregulated CDK5 which is 
expected to cause subsequent p53 upregulation / apoptosis and SpeedyRINGO acts 
as an anti-apoptotic factor in those neurons by inhibiting CDK5 upregulation. 
Although there was no upregulation of mitotic markers in SpeedyRINGO expressing 
neurons, it was determined that only CDK2 protein expression was upregulated in 
SpeedyRINGO expressing neurons. It was actually expected because CDK2 is the 
partner of SpeedyRINGO, and over expression of SpeedyRINGO induced its 
partner’s expression so that it can properly function when necessary. 
In addition to its role in cell cycle re-activation attempt, calpain has also been shown 
to activate apoptotic machinery by increasing p53 level in degenerating neurons. 
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Western blotting studies showed that both calpain activation indeed lead to up-
regulation of p53 in the absence / presence of SpeedyRINGO. As explained 
previously, calpain up-regulates p53 either directly (through regulating its 
transcription) or indirectly (via CDK5).  
In this study, it has also been shown that SpeedyRINGO maintains CDK5 in its 
regular levels when it is expressed in neurons. In spite of this, it appears that 
SpeedyRINGO was not able to act on the activity of calpain since in neurons that 
were expressing SpeedyRINGO, p53 was still up-regulated. While this up-regulation 
results from the activation of calpain, which in turn, causes apoptosis, p53 presence 
is also needed by SpeedyRINGO for inhibiting the activity of caspase-3. Hence, in 
both situations, the p53 level is in favor of SpeedyRINGO since SpeedyRINGO can 
be effective in the inhibition of caspase-3 activation only when p53 is present, as 
shown before in mitotic cells (McAndrew, 2009; Gastwirt, 2006). Therefore, for 
SpeedyRINGO to further inhibit caspase-3, an increase in p53 in apoptosis is 
required, consistent with the critical role of p53 at the pendulum of cell cycle arrest 
and apoptosis.  
p27 was also analyzed in mRNA and protein level for the reason that it is a general 
cell cycle inhibitor and also known as tumor-suppressor protein. Moreover, calpain 
over-activation has been shown to upregulate p27 levels, which has been accepted as 
a marker for apoptosis. Our results showing the elevation of mRNA and protein 
levels of p27
kip
 in only calpain-induced case may indicate a possible reactive effort 
of neurons to inhibit cell cycle re-activation and may also indicate the presence of 
apoptosis in those neurons. p27
kip
 level was decreased 20% in SpeedyRINGO 
expressing calpain-induced neurons compared to only calpain-induced neurons. All 
these results may also imply that SpeedyRINGO keeps neurons under stable 
conditions by avoiding chaotic cell cycle re-entry upon calpain induction, and 
therefore, there is no need to put a p27
kip
 brake on this cell cycle activation. The 
presence of SpeedyRINGO may also have a pro-active effect on p27
kip
 by preventing 
its up-regulation. 
One of the main goals of this study was to analyze protective and recovery effect of 
SpeedyRINGO on calpain-based apoptosis in degenerating neurons. Therefore, the 
key question in this study was whether SpeedyRINGO could prevent calpain-
mediated caspase-3 activation in adult neurons. Results of western blotting indicated 
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a 1.37 fold increase in active caspase-3 levels in calpain-induced neurons indicating 
the activation of apoptotic machinery. This caspase-3 level increase was contributive 
that calpain induction could lead neurons re-activate their cell cycle and force them 
undergo apoptosis through caspase-3 activation. In contrast with the apoptotic effect 
of calpain, SpeedyRINGO was shown to be anti-apoptotic by inhibiting caspase-3 
activation in calpain-overactivated neurons. These results evidently point out that 
SpeedyRINGO impedes the progress of calpain-mediated apoptosis by preventing 
the activation of caspase-3 in degenerating neurons.  
In addition to all these findings, It was noteworthy that fold changes in both 
transcriptional and translational level of analyzed proteins were all significant but not 
too high. Since a low concentration of calcium ionophore and a short time period of 
incubation were chosen for calpain over-activity experiments in order to prevent 
sudden and rapid apoptotic death of neurons.  It was noteworthy to see how 
significant the results were even in case low level of fold changes in cyclins. This 
would enable visualizing the gradual progression of calpain-mediated apoptotic and 
neurodegenerative pathway and also the effect of SpeedyRINGO on this progression. 
Together with these results, TUNEL analysis also indicated that there was 65% 
TUNEL-positive neurons in only calpain-induced neuron population, whereas no 
TUNEL-positive neuron was detected in the SpeedyRINGO expressing calpain-
induced neuron population, and this supports the idea that SpeedyRINGO could 
inhibit caspase-dependent apoptosis in degenerating neurons.  
Besides TUNEL analysis, DAPI staining also showed that over-activation of calpain 
resulted in condensation of the DNA and it also caused the enlargement of the nuclei, 
which is an indicator of the starting of DNA fragmentation indicating the early-
apoptotic process in neurons. However, SpeedyRINGO transfected calpain-
overactivated neurons had intact nuclei that did not show any sign of DNA 
condensation and nuclear enlargement. This findings support the hypothesis that 
SpeedyRINGO may prevent calpain-mediated apoptosis in neurons. 
Moreover, cytotoxicity analysis also supported other findings that calpain induction 
and over-activation caused relatively more cytotoxicity in neurons (29.53%), while 
SpeedyRINGO expression drastically recover the cytotoxic effect of calpain 
induction by decreasing the cytotoxicity level to 10.91%. 
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To summarize, calpain over-activation was indeed an important neurodegenerative 
and apoptotic factor for neurons and results of this study showed for the first time 
that SpeedyRINGO, a specific cell cycle regulator, prevented this adverse effect of 
calpain by inhibiting caspase-mediated apoptosis in post-mitotic neurons.  
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5.  CONCLUSIONS 
It was shown for the first time that, mitotic cell specific regulator, SpeedyRINGO 
was protective against calpain-mediated apoptosis in terminally differentiated post-
mitotic neurons. The results indicate that calpain induction forces neurons to re-enter 
cell cycle and drive them into apoptosis by increasing p53 expression and activating 
caspase-3, which is a landmark of caspase-dependent apoptosis. Conversely, 
presence of SpeedyRINGO in calpain-induced neurons prevented caspase-3 
activation in a p53-dependent manner.  
It was of primary importance to find a way to protect neurons against apoptotic effect 
of calpain over-activity, as pathological induction of intrinsic calpain has been shown 
to be a serious cause of cell cycle re-activation and subsequent apoptosis in 
degenerating neurons. It would also be worthwhile in terms of giving researchers 
new therapeutic insights to overcome the deadly progression of neurodegenerative 
diseases.  
Although, the exact mechanism for the protective effect of SpeedyRINGO in calpain 
mediated apoptosis requires further analysis, based on the maintained presence of 
p53 in SpeedyRINGO expressing neurons, it could be speculated that the effects are 
not based on the direct inhibition of calpain activity as calpain causes p53 increase, it 
is rather at the downstream of this pathway.  The most direct effects of 
SpeedyRINGO might be related with the activity of caspase-3. 
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